# OMIM_ID,phenotypes,gene_name,gene_symbols,cyto_loc,
OMIM:115665,"Cataract 8, multiple types (2)","Cataract, congenital, Volkmann type","CTRCT8, CCV",1pter-p36.13,
OMIM:607671,"Dystonia 13, torsion (2)","Dystonia 13, torsion",DYT13,1p36.32-p36.13,
OMIM:606242,Kondoh syndrome (2),"Kondoh syndrome (mental retardation, microcephaly, growth retardation, joint contractures, and facial dysmorphism)",KONDS,1p36.32-p35.3,
OMIM:614414,"Deafness, autosomal recessive 96 (2)","Deafness, autosomal recessive 96",DFNB96,1p36.31-p36.13,
OMIM:609918,Gallbladder disease 2 (2),Gallbladder disease 2,GBD2,1p36.21,
OMIM:608543,"{Schizophrenia 12}, 181500 (2)",Schizophrenia 12,SCZD12,1p36.2,
OMIM:600975,"Glaucoma 3, primary infantile, B (2)","Glaucoma 3, primary infantile, B",GLC3B,1p36.2-p36.1,
OMIM:609122,"Aneurysm, intracranial berry, 3 (2)","Aneurysm, intracranial berry, 3",ANIB3,1p36.13-p34.3,
OMIM:616055,"Episodic ataxia, type 8 (2)","Episodic ataxia, type 8",EA8,1p36.13-p34.3,
OMIM:612957,{Vitamin B6 plasma level QTL 1} (2),Vitamin B6 plasma level QTL 1,B6QTL1,1p36.12,
OMIM:612627,"Seizures, benign familial infantile, 4 (2)","Seizures, benign familial infantile, 4","BFIS4, BFIC4",1p36.12-p35.1,
OMIM:612367,"{Alkaline phosphatase, plasma level of, QTL 2} (2)","Alkaline phosphatase, plasma level of, QTL 2",ALPQTL2,1p36,
OMIM:605462,"{Basal cell carcinoma, susceptibility to, 1} (2)","Basal cell carcinoma, susceptibility to, 1",BCC1,1p36,
OMIM:606928,[Bone mineral density QTL 3] (2),Bone mineral density QTL 3,BMND3,1p36,
OMIM:155600,"{Melanoma, cutaneous malignant, 1} (2)",Cutaneous malignant melanoma/dysplastic nevus,"CMM, MLM, DNS",1p36,
OMIM:607872,Chromosome 1p36 deletion syndrome (4),Chromosome 1p36 deletion syndrome,"DEL1p36, C1DELp36",1p36,
OMIM:605225,{Inflammatory bowel disease 7} (2),Inflammatory bowel disease 7,IBD7,1p36,
OMIM:612596,"{Multiple sclerosis, susceptibility to, 4} (2)","Multiple sclerosis, susceptibility to, 4",MS4,1p36,
OMIM:610320,Myopia 14 (2),Myopia 14,MYP14,1p36,
OMIM:607317,"Spinocerebellar ataxia, autosomal recessive 4 (2)","Spinocerebellar ataxia, autosomal recessive 4","SCAR4, SCASI",1p36,
OMIM:608995,"{Dyslexia, susceptibility to, 8} (2)","Dyslexia, susceptibility to, 8",DYX8,1p36-p34,
OMIM:609919,Gallbladder disease 3 (2),Gallbladder disease 3,GBD3,1p34.3,
OMIM:612968,"Cataract 34, multiple types (2)","Cataract 34, multiple types","CTRCT34, CATC3",1p34.3-p32.2,
OMIM:178300,"Ptosis, hereditary congenital, 1 (2)","Ptosis, congenital 1, autosomal dominant",PTOS1,1p34.1-p32,
OMIM:613545,Macrostomia (2),Macrostomia,MACST,1p34-p32,
OMIM:613857,Orofacial cleft 13 (2),Orofacial cleft 13,OFC13,1p33,
OMIM:612728,[Bone mineral density QTL 14] (2),Bone mineral density quantitative trait locus 14,BMND14,1p33-p32,
OMIM:613606,Forsythe-Wakeling syndrome (2),Forsythe-Wakeling syndrome,FWS,1p33-p31.1,
OMIM:606852,{Parkinson disease 10} (2),Parkinson disease 10,"PARK10, AAOPD",1p32,
OMIM:615945,Spinocerebellar ataxia 37 (2),Spinocerebellar ataxia 37,SCA37,1p32,
OMIM:613548,{Stature QTL 23} (2),Stature quantitative trait locus 23,STQTL23,1p32,
OMIM:613735,Chromosome 1p32-p31 deletion syndrome (4),Chromosome 1p32-p31 deletion syndrome,"DEL1p32p31, C1DELp32p31",1p32-p31,
OMIM:164750,Omphalocele due to duplication of 1p31.3 (4),Omphalocele due to duplication of 1p31.3,"OPHLC, C1DUPp31.3, DUP1p31.3",1p31.3,
OMIM:612293,"Porokeratosis 5, disseminated superficial actinic (2)","Porokeratosis 5, disseminated superficial actinic","POROK5, DSAP3",1p31.3-p31.1,
OMIM:613008,"{Biliary cirrhosis, primary, 3} (2)","Biliary cirrhosis, primary, 3",PBC3,1p31.2,
OMIM:609727,"Spastic paraplegia 29, autosomal dominant (2)","Spastic paraplegia 29, autosomal dominant",SPG29,1p31.1-p21.1,
OMIM:601676,Acute insulin response (2),Acute insulin response,AIR,1p31,
OMIM:610906,"{Asthma-related traits, susceptibility to, 4} (2)","Asthma-related traits, susceptibility to, 4",ASRT4,1p31,
OMIM:615892,Orofacial cleft 14 (2),Orofacial cleft 14,OFC14,1p31,
OMIM:606787,Peripheral arterial occlusive disease 1 (2),Peripheral arterial occlusive disease 1,PAOD1,1p31,
OMIM:606215,"{Atrioventricular septal defect, susceptibility to, 1} (2)","Atrioventricular septal defect, susceptibility to, 1","AVSD1, AVCD",1p31-p21,
OMIM:608653,"Deafness, autosomal recessive 32 (2)","Deafness, autosomal recessive 32",DFNB32,1p22.1-p13.3,
OMIM:608035,"{Melanoma, cutaneous malignant, 4} (2)","Melanoma, cutaneous malignant, 4",CMM4,1p22,
OMIM:611381,"{Kala-azar, susceptibility to, 2} (2)","Kala-azar, susceptibility to, 2",KAZA2,1p22,
OMIM:609913,Retinitis pigmentosa 32 (2),Retinitis pigmentosa-32,RP32,1p21.3-p13.3,
OMIM:611107,"Mental retardation, autosomal recessive, 4 (2)","Mental retardation, autosomal recessive, 4",MRT4,1p21.1-p13.3,
OMIM:612841,Hypotrichosis 5 (2),Hypotrichosis 5,"HYPT5, MUHH2",1p21.1-q21.3,
OMIM:609822,{Stature QTL 7} (2),Stature quantitative trait locus 7,STQTL7,1p21,
OMIM:600193,"Waardenburg syndrome, type 2B (2)","Waardenburg syndrome, type 2B",WS2B,1p21-p13.3,
OMIM:193000,Vesicoureteral reflux (2),Vesicoureteral reflux,VUR,1p13,
OMIM:606788,"{Anorexia nervosa, susceptibility to, 1} (2)","Anorexia nervosa, susceptibility to, 1",ANON1,1p,
OMIM:605606,{Psoriasis susceptibility 7} (2),Psoriasis susceptibility 7,PSORS7,1p,
OMIM:605549,Cone-rod dystrophy 8 (2),Cone-rod dystrophy 8,CORD8,1q12-q24,
OMIM:611152,{Alzheimer disease-13} (2),Alzheimer disease-13,AD13,1q21,
OMIM:603935,{Psoriasis susceptibility 4} (2),Psoriasis susceptibility 4,PSORS4,1q21,
OMIM:605642,"Thyroid carcinoma, papillary, with papillary renal neoplasia (2)",Papillary thyroid carcinoma with papillary renal neoplasia,"PTCPRN, PRN1",1q21,
OMIM:161900,Nephropathy-hypertension (2),"Renal failure, progressive, with hypertension","RFH1, AORF",1q21,
OMIM:608781,{Asperger syndrome susceptibility 3} (2),"Asperger syndrome, susceptibility to, 3",ASPG3,1q21-q22,
OMIM:605833,[Bone mineral density QTL 2] (2),Bone mineral density QTL 2,BMND2,1q21-q23,
OMIM:601412,"Deafness, autosomal dominant 7 (2)","Deafness, autosomal dominant 7",DFNA7,1q21-q23,
OMIM:608372,"Deafness, autosomal dominant 49 (2)","Deafness, autosomal dominant 49",DFNA49,1q21-q23,
OMIM:613145,"{Systemic lupus erythematosus, susceptibility to, 14} (2)","Systemic lupus erythematosus, susceptibility to, 14",SLEB14,1q21-q23,
OMIM:612474,Chromosome 1q21.1 deletion syndrome (4),Chromosome 1q21.1 deletion syndrome,"DEL1q21, C1DELq21",1q21.1,
OMIM:612475,Chromosome 1q21.1 duplication syndrome (4),Chromosome 1q21.1 duplication syndrome,"DUP1q21, C1DUPq21",1q21.1,
OMIM:613017,"{Neuroblastoma, susceptibility to, 6} (2)","Neuroblastoma, susceptibility to, 6",NBLST6,1q21.1,
OMIM:614747,"[Uric acid concentration, serum, QTL6] (2)","Uric acid concentration, serum, quantitative trait locus 6",UAQTL6,1q21.1,
OMIM:139450,"Hair, curly (2)",Hair morphology 2 (curly hair),HRM2,1q21.3,
OMIM:605913,"Bleeding disorder, east Texas type (2)","Bleeding disorder, east Texas type",BDET,1q23,
OMIM:609266,Li-Fraumeni syndrome 3 (2),Li-Fraumeni syndrome 3,LFS3,1q23,
OMIM:610141,"[QT interval, variation in] (2)","QT interval, variation in",QTV,1q23.3,
OMIM:605429,"{Deafness, nonsyndromic, modifier 1} (2)","Deafness, nonsyndromic, modifier 1",DFNM1,1q24,
OMIM:270750,Spastic paraplegia 23 (2),Spastic paraplegia 23,SPG23,2q24-q32,
OMIM:611154,{Alzheimer disease-14} (2),Alzheimer disease 14,AD14,1q25,
OMIM:608526,"Periodontitis, aggressive, 2 (2)","Periodontitis, aggressive, 2",PDON2,1q25,
OMIM:120502,Branchiootic syndrome 2 (2),Branchiootic syndrome 2,BOS2,1q31,
OMIM:612005,"{Celiac disease, susceptibility to, 7} (2)","Celiac disease, susceptibility to, 7",CELIAC7,1q31,
OMIM:607516,"{Migraine with or without aura, susceptibility to, 6} (2); {Migraine, familial hemiplegic, 4} (2)","Migraine, several forms","MGR6, FHM3",1q31,
OMIM:176780,"{Pelvic organ prolapse, susceptibility to, 1} (2)","Pelvic organ prolapse, susceptibility to, 1",PVOP1,1q31,
OMIM:145260,"Pseudohypoaldosteronism, type IIA (2)",Pseudohypoaldosteronism type IIA,"PHA2A, PHA2",1q31-q42,
OMIM:609454,"Supranuclear palsy, progressive, 2 (2)","Supranuclear palsy, progressive, 2",PSNP2,1q31.1,
OMIM:614826,"Nystagmus 7, congenital, autosomal dominant (2)","Nystagmus 7, congenital, autosomal dominant",NYS7,1q31.3-q32.1,
OMIM:137950,Glomerulopathy with fibronectin deposits 1 (2),Glomerulopathy with fibronectin deposits 1,GFND1,1q32,
OMIM:613164,{Parkinson disease 16} (2),Parkinson disease 16,PARK16,1q32,
OMIM:140400,"Progressive familial heart block, type II (2)","Progressive familial heart block, type II",PFHB2,1q32,
OMIM:612381,{Inflammatory bowel disease 23} (2),Inflammatory bowel disease 23,IBD23,1q32.1,
OMIM:600332,Rippling muscle disease-1 (2),Rippling muscle disease 1,RMD1,1q41,
OMIM:610836,{Autism susceptibility 11} (2),"Autism, susceptibility to, 11",AUTS11,1q41-q42,
OMIM:612530,Chromosome 1q41-q42 deletion syndrome (4),Chromosome 1q41-q42 deletion syndrome,"DEL1q41q42, C1DELq41q42",1q41-q42,
OMIM:615589,Otosclerosis 10 (2),Otosclerosis 10,OTSC10,1q41-q44,
OMIM:613058,"{Basal cell carcinoma, susceptibility to, 2} (2)","Basal cell carcinoma, susceptibility to, 2",BCC2,1q42,
OMIM:606554,"Episodic ataxia, type 3 (2)","Episodic ataxia, type 3",EA3,1q42,
OMIM:604801,"Muscular dystrophy, congenital, 1B (2)","Muscular dystrophy, congenital, 1B",MDC1B,1q42,
OMIM:602759,"{Prostate cancer, susceptibility to}, 176807 (2)",Predisposing for prostate cancer,PCAP,1q42.2-q43,
OMIM:119100,Split-hand/foot malformation with long bone deficiency 1 (2),Split-hand/foot malformation with long bone deficiency 1,"SHFL1, SHFLD",1q42.2-q43,
OMIM:612433,"Deafness, autosomal recessive 45 (2)","Deafness, autosomal recessive 45",DFNB45,1q43-q44,
OMIM:108420,Spermatogenic failure 2 (2),Spermatogenic failure 2,"SPGF2, ASG",Chr.1,
OMIM:115800,"Cataract 29, coralliform (2)","Cataract 29, coralliform",CTRCT29,2pter-p24,
OMIM:609946,"Deafness, neurosensory, autosomal recessive 47 (2)","Deafness, neurosensory, autosomal recessive 47",DFNB47,2p25.1-p24.3,
OMIM:609402,Preeclampsia/eclampsia 2 (2),Preeclampsia/eclampsia 2,PEE2,2p25,
OMIM:602134,"Tremor, hereditary essential, 2 (2)","Tremor, hereditary essential, 2","ETM2, ETM",2p25-p22,
OMIM:607329,"{Hypertension, essential, susceptibility to, 3}, 145500 (2)","Hypertension, essential, susceptibility to, 3",HYT3,2p25-p24,
OMIM:101850,"?Keratoderma, palmoplantar, punctate type 3 (2)","Keratoderma, palmoplantar, punctate type III",PPKP3,2p25-p12,
OMIM:610760,[Cholesterol level QTL 2] (2),Cholesterol level quantitative trait locus 2,CLQTL2,2p24-p22,
OMIM:609800,"Epilepsy, generalized, with febrile seizures plus, type 4 (2)","Generalized epilepsy with febrile seizures plus, type 4",GEFSP4,2p24,
OMIM:609271,Keratoconus 4 (2),Keratoconus 4,KTCN4,2p24,
OMIM:609955,"Fibromatosis, gingival, 3 (2)","Fibromatosis, gingival, 3","GINGF3, HGF3, GGF3",2p23.3-p22.3,
OMIM:114580,"Candidiasis, familial, 1, autosomal dominant (2)","Candidiasis, familial, 1","CANDF1, CMCT",2p22.3-p21,
OMIM:614227,"Hyperuricemic nephropathy, familial juvenile, 3 (2)","Hyperuricemic nephropathy, familial juvenile, 3",HNFJ3,2p22.1-p21,
OMIM:606407,Hypotonia-cystinuria syndrome (4),Homozygous 2p21 deletion syndrome,"DEL2p21, C2DELp21",2p21,
OMIM:601694,[Leptin serum levels QTL1] (2),Leptin serum levels quantitative trait locus 1,"LEPQTL1, LSL",2p21,
OMIM:608703,Spinocerebellar ataxia 25 (2),Spinocerebellar ataxia 25,SCA25,2p21-p13,
OMIM:615654,"Deafness, autosomal dominant 58 (2)","Deafness, autosomal dominant 58",DFNA58,2p21-p12,
OMIM:142335,[Fetal hemoglobin QTL5] (2),Fetal hemoglobin quantitative trait locus 5,HBFQTL5,2p16.1,
OMIM:612513,Chromosome 2p16.1-p15 deletion syndrome (4),Chromosome 2p16.1-p15 deletion syndrome,"DEL2p16.1-p15, C2DELp161-p15",2p16.1-p15,
OMIM:609958,"{Asthma-related traits, susceptibility to, 3} (2)","Asthma-related traits, susceptibility to, 3",ASRT3,2p16,
OMIM:605244,"Carney complex, type II (2)","Carney complex, type II",CNC2,2p16,
OMIM:613549,{Stature QTL 24} (2),Stature quantitative trait locus 24,STQTL24,2p16,
OMIM:604254,"{Dyslexia, susceptibility to, 3} (2)","Dyslexia, susceptibility to, 3",DYX3,2p16-p15,
OMIM:611276,"Glaucoma 1, open angle, H (2)","Glaucoma 1, open angle, H",GLC1H,2p16-p15,
OMIM:610071,Hyperparathyroidism 3 (2),Hyperparathyroidism 3,HRPT3,2p14-p13.3,
OMIM:612853,{Restless legs syndrome 7} (2),"Restless legs syndrome, susceptibility to, 7",RLS7,2p14-p13,
OMIM:602966,Orofacial cleft-2 (2),Orofacial cleft-2,OFC2,2p13,
OMIM:189800,Preeclampsia/eclampsia 1 (2),Preeclampsia/eclampsia 1,"PEE1, PREG1",2p13,
OMIM:602404,{Parkinson disease 3} (2),Parkinson disease 3,PARK3,2p13,
OMIM:607304,"Cataract 27, nuclear progressive (2)","Cataract 27, nuclear progressive","CTRCT27, CCNP",2p12,
OMIM:608394,"Deafness, autosomal dominant 43 (2)","Deafness, autosomal dominant 43",DFNA43,2p12,
OMIM:613564,Chromosome 2p12-p11.2 deletion syndrome (4),Chromosome 2p12-p11.2 deletion syndrome,"DEL2p12p11.2, C2DELp12p11.2",2p12-p11.2,
OMIM:139900,[Handedness] (2),"Hand skill, relative",HSR,2p12-q22,
OMIM:606689,"Glaucoma 1B, primary open angle, adult onset, (2)","Glaucoma 1, open angle, B (adult-onset)",GLC1B,2cen-q13,
OMIM:606053,{Autism susceptibility 5} (2),"Autism, susceptibility to, 5",AUTS5,2q,
OMIM:606963,"Pulmonary disease, chronic obstructive, severe early-onset (2)","Pulmonary disease, chronic obstructive, severe early-onset",COPD,2q,
OMIM:612006,"{Celiac disease, susceptibility to, 8} (2)","Celiac disease, susceptibility to, 8",CELIAC8,2q11-q12,
OMIM:611897,Nanophthalmos 3 (2),Nanophthalmos 3,NNO3,2q11-q14,
OMIM:257550,"Oculomotor apraxia, congenital, Cogan-type (2)",Cogan-type congenital oculomotor apraxia,COMA,2q13,
OMIM:604288,"Cardiomyopathy, dilated, 1H (2)","Cardiomyopathy, dilated, 1H",CMD1H,2q14-q22,
OMIM:612459,[Body mass index QTL13] (2),Body mass index quantitative trait locus 13,BMIQ13,2q14.1,
OMIM:614588,Dystonia 21 (2),Dystonia 21,DYT21,2q14.3-q21.3,
OMIM:606240,"{Thyroid carcinoma, nonmedullary, 3} (2)",Nonmedullary thyroid carcinoma 3,NMTC3,2q21,
OMIM:612311,"{Attention deficit-hyperactivity disorder, susceptibility to, 5} (2)","Attention deficit-hyperactivity disorder, susceptibility to, 5",ADHD5,2q21.1,
OMIM:608316,"{Coronary heart disease, susceptibility to, 2} (2)","Coronary heart disease, susceptibility to, 2",CHDS2,2q21.1-q22,
OMIM:611535,{Major affective disorder 5} (2),Major affective disorder 5,MAFD5,2q22-q24,
OMIM:603964,"Deafness, autosomal dominant 16 (2)","Deafness, autosomal dominant 16",DFNA16,2q23-q24.3,
OMIM:605818,"Deafness, autosomal recessive 27 (2)","Deafness, autosomal recessive 27",DFNB27,2q23-q31,
OMIM:612108,[Fasting plasma glucose level QTL 1] (2),Fasting plasma glucose level QTL 1,FGQTL1,2q24-q32,
OMIM:156232,"Mesomelic dysplasia, Kantaputra type (2)","Mesomelic dysplasia, Kantaputra type","MMDK, MDK",2q24-q32,
OMIM:612759,Synesthesia (2),Synesthesia,SYNSTH,2q24.1,
OMIM:610295,{Intelligence QTL3} (2),Intelligence quantitative trait locus 3,INTLQ2,2q24.1-q31.1,
OMIM:610155,"{Diabetes mellitus, insulin-dependent, 19} (2)","Diabetes mellitus, insulin-dependent, 19",IDDM19,2q24.3,
OMIM:600321,"{Diabetes mellitus, insulin-dependent, 7} (2)",Insulin-dependent diabetes mellitus-7,IDDM7,2q31,
OMIM:611147,Paroxysmal nonkinesigenic dyskinesia 2 (2),Paroxysmal nonkinesigenic dyskinesia 2,PNKD2,2q31,
OMIM:606708,Split-hand/foot malformation 5 (2),Split-hand/foot malformation 5,SHFM5,2q31,
OMIM:613681,Chromosome 2q31.1 duplication syndrome (4),Chromosome 2q31.1 duplication syndrome,"DUP2q31.1, C2DUPq31.1",2q31.1,
OMIM:612345,Chromosome 2q31.2 deletion syndrome (4),Chromosome 2q31.2 deletion syndrome,DEL2q31,2q31.2,
OMIM:187370,"Arthrogryposis, distal, type 10 (2)","Arthrogryposis, distal, type 10",DA10,2q31.3-q32.1,
OMIM:612361,"{Schizophrenia, susceptibility to, 14} (2)",Schizophrenia 14,SCZD14,2q32.1,
OMIM:602087,Arrhythmogenic right ventricular dysplasia 4 (2),Arrhythmogenic right ventricular dysplasia 4,ARVD4,2q32.1-q32.3,
OMIM:610439,{Restless legs syndrome 4} (2),"Restless legs syndrome, susceptibility to, 4",RLS4,2q33,
OMIM:614280,"{Epilepsy, juvenile myoclonic, susceptibility to, 9} (2)","Epilepsy, juvenile myoclonic, susceptibility to, 9",EJM9,2q33-q36,
OMIM:612586,"{Aneurysm, intracranial berry, 9} (2)","Aneurysm, intracranial berry, 9",ANIB9,2q33.1,
OMIM:610839,{Osteoarthritis susceptibility 4} (2),Osteoarthritis susceptibility 4,"OS4, GOA1",2q33.3,
OMIM:601318,"{Diabetes mellitus, insulin-dependent, 13} (2)",Insulin-dependent diabetes mellitus-13,IDDM13,2q34,
OMIM:607966,"{Systemic lupus erythematosus with nephritis, susceptibility to, 2} (2)","Systemic lupus erythematosus with nephritis, susceptibility to, 2",SLEN2,2q34-q35,
OMIM:185900,"Syndactyly, type 1 (4); Craniosynostosis, Philadelphia type, 185900 (4)","Chromosome 2q35 duplication syndrome (syndactyly, type I)","DUP2q35, C2DUPq35, SDTY1, SD1",2q34-q36,
OMIM:607949,"{Tuberculosis, susceptibility to} (2)","Mycobacterium tuberculosis, susceptibility to infection by",MTBS1,2q35,
OMIM:613016,"{Neuroblastoma, susceptibility to, 5} (2)","Neuroblastoma, susceptibility to, 5",NBLST5,2q35,
OMIM:609153,"Pseudohyperkalemia, familial, 2, due to red cell leak (2)","Pseudohyperkalemia, familial, 2, due to red cell leak",PSHK2,2q35-q36,
OMIM:102510,Acropectorovertebral dysplasia (2),Acropectorovertebral dysplasia (F syndrome),ACRPV,2q36,
OMIM:613944,"{IgA nephropathy, susceptibility to, 2} (2)","IgA nephropathy, susceptibility to, 2",IGAN2,2q36,
OMIM:613238,"{Spondyloarthropathy, susceptibility to, 3} (2)","Spondyloarthropathy, susceptibility to, 3",SPDA3,2q36.1-q36.3,
OMIM:613658,Rajab syndrome (2),Rajab syndrome,RJBS,2q36.2,
OMIM:600430,Chromosome 2q37 deletion syndrome (4),Chromosome 2q37 deletion syndrome,"BDMR, C2DELq37, DEL2q37",2q37,
OMIM:606656,"Basal ganglia calcification, idiopathic, 2 (2)","Basal ganglia calcification, idiopathic, 2",IBGC2,2q37,
OMIM:609995,Myopia 12 (2),Myopia 12,MYP12,2q37.1,
OMIM:613440,{Stature QTL 21} (2),Stature quantitative trait locus 21,STQTL21,2q37.1,
OMIM:605934,Holoprosencephaly-6 (2),Holoprosencephaly 6,HPE6,2q37.1-q37.3,
OMIM:613792,3p- syndrome (4),3p- syndrome (chromosome 3pter-p25 deletion syndrome),"DEL3pterp25, C3DELpterp25",3pter-p25,
OMIM:612976,{Age-related hearing impairment 2} (2),Age-related hearing impairment 2,ARHI2,3p26.1-p25.1,
OMIM:609299,"{Prostate cancer, hereditary, 5}, 176807 (2)","Prostate cancer, hereditary, 5",HPC5,3p26,
OMIM:608448,{Inflammatory bowel disease 9} (2),Inflammatory bowel disease 9,IBD9,3p26,
OMIM:608982,{Stature QTL 5} (2),Stature quantitative trait locus 5,STQTL5,3p26,
OMIM:252350,Moyamoya disease (2),Moyamoya disease,"MYMY1, MYMY",3p26-p24.2,
OMIM:606661,"{Melanoma, uveal, susceptibility to, 2} (2)","Melanoma, uveal, susceptibility to, 2",UVM2,3p25.2-p25.1,
OMIM:607893,"{Ovarian cancer, susceptibility to} (2)","Ovarian cancer, susceptibility to, 1",OVCAS1,3p25-p22,
OMIM:613530,"Muscular dystrophy, limb-girdle, type 1H (2)","Muscular dystrophy, limb-girdle, type 1H",LGMD1H,3p25.1-p23,
OMIM:612401,{Osteoarthritis susceptibility 6} (2),Osteoarthritis susceptibility 6,OS6,3p24.3,
OMIM:611634,"Febrile seizures, familial, 9 (2)","Febrile seizures, familial, 9",Feb9,3p24.2-p23,
OMIM:613519,"{Dermatitis, atopic, susceptibility to, 9} (2)","Dermatitis, atopic, 9",ATOD9,3p24,
OMIM:608088,"Neuropathy, hereditary sensory, type IB (2)","Hereditary sensory neuropathy, type IB",HSN1B,3p24-p22,
OMIM:609954,{Asperger syndrome susceptibility 4} (2),"Asperger syndrome, susceptibility to, 4",ASPG4,3p24-p21,
OMIM:182280,Small-cell cancer of lung (2),Small-cell cancer of lung,SCLC1,3p23-p21,
OMIM:615612,Developmental dysplasia of the hip 2 (2),Developmental dysplasia of the hip 2,DDH2,3p22.2,
OMIM:614836,"{Human herpesvirus 8, susceptibility to} (2)","Human herpesvirus 8, susceptibility to",HHV8S,3p22,
OMIM:609815,Zygodactyly 1 (2),Zygodactyly 1,ZD1,3p21.31,
OMIM:612241,{Inflammatory bowel disease 12} (2),Inflammatory bowel disease 12,IBD12,3p21.3,
OMIM:612007,"{Celiac disease, susceptibility to, 9} (2)","Celiac disease, susceptibility to, 9",CELIAC9,3p21,
OMIM:606874,"{Hirschsprung disease, susceptibility to, 6} (2)","Hirschsprung disease, susceptibility to, 6",HSCR6,3p21,
OMIM:613806,"Cholangitis, primary sclerosing (2)","Cholangitis, primary sclerosing",PSC,3p21,
OMIM:612574,[Mean platelet volume QTL2] (2),Mean platelet volume quantitative trait locus 2,MPVQTL2,3p21-p13,
OMIM:610948,"{Hypertension, essential, susceptibility to, 7} (2)","Hypertension, essential, susceptibility to, 7",HYT7,3p14.1-q12.3,
OMIM:608586,Keratoconus 3 (2),Keratoconus 3,KTCN3,3p14-q13,
OMIM:606896,"{Dyslexia, susceptibility to, 5} (2)","Dyslexia, susceptibility to, 5",DYX5,3p12-q13,
OMIM:608445,{Speech-sound disorder} (2),Speech-sound disorder,SSD,3p12-q13,
OMIM:109720,"Biliary cirrhosis, primary, 1 (2)","Biliary cirrhosis, primary, 1",PBC1,3p12-q13.2,
OMIM:607135,Creatinine clearance QTL (2),Creatinine clearance QTL,CRCL,3p,
OMIM:114200,Camptodactyly 1 (2),Camptodactyly 1,CAMPD1,3q11.2-q13.12,
OMIM:600467,{Malignant hyperthermia susceptibility 4} (2),Malignant hyperthermia susceptibility 4,MHS4,3q13.1,
OMIM:614655,"Stuttering, familial persistent, 3 (2)","Stuttering, familial persistent, 3",STUT3,3q13.2-q13.33,
OMIM:615433,Chromosome 3q13.31 deletion syndrome (4),Chromosome 3q13.31 deletion syndrome,"DEL3q13.31, C13DELq13.31",3q13.31,
OMIM:603165,"{Dermatitis, atopic, susceptibility to, 1} (2)","Dermatitis, atopic, 1",ATOD1,3q21,
OMIM:613460,"[Fasting plasma glucose level QTL 6] (2); [Birth weight QTL 3] (2); [Plasma glucose, 2-hour, QTL 1] (2)","Fasting plasma glucose level QTL 6; Birth weight QTL 3; Plasma glucose, 2-hour, QTL 1","FGQTL6, BWQTL3, PGQTL1",3q21,
OMIM:604316,{Psoriasis susceptibility 5} (2),Psoriasis susceptibility 5,PSORS5,3q21,
OMIM:601471,"Facial paresis, hereditary congenital, 1 (2)","Facial paresis, hereditary congenital, 1","HCFP1, MBS2",3q21-q22,
OMIM:601682,"Glaucoma 1C, primary open angle (2)","Glaucoma 1, open angle, C",GLC1C,3q21-q24,
OMIM:606012,"Deafness, autosomal dominant 18 (2)","Deafness, autosomal dominant 18",DFNA18,3q22,
OMIM:606995,Senior-Loken syndrome 3 (2),Senior-Loken syndrome 3,SLSN3,3q22,
OMIM:611155,{Alzheimer disease-15} (2),Alzheimer disease 15,AD15,3q22-q24,
OMIM:220200,Dandy-Walker syndrome (4),Dandy-Walker syndrome,"DWS, C3DELq22q24, DEL3q22q24",3q22-q24,
OMIM:608787,Otosclerosis 5 (2),Otosclerosis 5,OTSC5,3q22-q24,
OMIM:612221,{Stature QTL 10} (2),Stature quantitative trait locus 10,STQTL10,3q23,
OMIM:610761,[High density lipoprotein cholesterol level QTL 5] (2),High density lipoprotein cholesterol level QTL 5,HDLCQ5,3q24-q26,
OMIM:606660,"{Melanoma, uveal, susceptibility to, 1} (2)","Melanoma, uveal, susceptibility to, 1",UVM1,3q24-q26,
OMIM:612008,"{Celiac disease, susceptibility to, 10} (2)","Celiac disease, susceptibility to, 10",CELIAC10,3q25-q26,
OMIM:615697,"Epilepsy, familial temporal lobe, 6 (2)","Epilepsy, familial temporal lobe, 6",ETL6,3q25-q26,
OMIM:608638,{Asperger syndrome susceptibility 1} (2),"Asperger syndrome, susceptibility to, 1",ASPG1,3q25-q27,
OMIM:607373,{Autism susceptibility 8} (2),"Autism, susceptibility to, 8",AUTS8,3q25-q27,
OMIM:613459,[Birth weight QTL 2] (2),Birth weight quantitative trait locus 2,BWQTL2,3q25.3,
OMIM:109200,"Alopecia, androgenetic, 1 (2)","Alopecia, androgenetic, 1","AFA1, MPB",3q26,
OMIM:609257,Myopia 8 (2),Myopia 8,MYP8,3q26,
OMIM:606082,"Goiter, multinodular, 3 (2)",Multinodular goiter-3,MNG3,3q26.1-q26.3,
OMIM:610422,Alopecia-mental retardation syndrome 2 (2),Alopecia-mental retardation syndrome 2,APMR2,3q26.2-q26.31,
OMIM:612637,"Febrile seizures, familial, 10 (2)","Febrile seizures, familial, 10",Feb10,3q26.2-q26.33,
OMIM:203650,Alopecia-mental retardation syndrome 1 (2),Alopecia-mental retardation syndrome 1,APMR1,3q26.3-q27.3,
OMIM:615127,"Epilepsy, myoclonic, familial adult, 4 (2)","Epilepsy, familial adult myoclonic, 4","FAME4, FCMTE4",3q26.32-q28,
OMIM:605552,Abdominal obesity-metabolic syndrome 1 (2),Abdominal obesity-metabolic syndrome QTL1,"AOMS1, SYNX",3q27,
OMIM:605229,"Spastic paraplegia 14, autosomal recessive (2)","Spastic paraplegia 14, autosomal recessive",SPG14,3q27-q28,
OMIM:612009,"{Celiac disease, susceptibility to, 11} (2)","Celiac disease, susceptibility to, 11",CELIAC11,3q28,
OMIM:614210,{Lung cancer susceptibility 5} (2),Lung cancer susceptibility 5,LNCR5,3q28,
OMIM:609425,Chromosome 3q29 microdeletion syndrome (4),Chromosome 3q29 microdeletion syndrome,"DEL3q29, MICRODEL3q29",3q29,
OMIM:611936,Chromosome 3q29 microduplication syndrome (4),Chromosome 3q29 microduplication syndrome,"DUP3q29, MICRODUP3q29",3q29,
OMIM:609456,"Muscular dystrophy, congenital, merosin-positive (2)","Muscular dystrophy, congenital, merosin-positive",MDCMP,4p16.3,
OMIM:194190,Wolf-Hirschhorn syndrome (4),Wolf-Hirschhorn syndrome,WHS,4p16.3,
OMIM:600593,"Craniosynostosis, Adelaide type (2)","Craniosynostosis, Adelaide type","CRSA, CRS3",4p16,
OMIM:611637,"Primary lateral sclerosis, adult, 1 (2)","Primary lateral sclerosis, adult, 1","PLSA1, PLSA",4p16,
OMIM:605480,"{Systemic lupus erythematosus, susceptibility to, 3} (2)","Systemic lupus erythematosus, susceptibility to, 3",SLEB3,4p16-p15.2,
OMIM:611863,Microtia with nasolacrimal duct imperforation and eye coloboma (1),Microtia with nasolacrimal duct imperforation and eye coloboma,MNDEC,4p16-p15,
OMIM:612335,"Spastic paraplegia 38, autosomal dominant (2)","Spastic paraplegia 38, autosomal dominant",SPG38,4p16-p15,
OMIM:603783,{Intelligence QTL1} (2),Intelligence quantitative trait locus 1,INTLQ1,4p16-q34,
OMIM:604802,Huntington disease-like 3 (2),Huntington disease-like 3,"HDL3, HLN2",4p15.3,
OMIM:612226,{Stature QTL 13} (2),Stature quantitative trait locus 13,STQTL13,4p15.3,
OMIM:607107,{Nasopharyngeal carcinoma 1} (2),Nasopharyngeal carcinoma 1,"NPC1, NPCA1",4p15.1-q12,
OMIM:607221,"Epilepsy, partial, with pericentral spikes (2)","Epilepsy, partial, with pericentral spikes",EPPS,4p15,
OMIM:608410,"{Obesity, susceptibility to, BMIQ7} (2)",Body mass index quantitative trait locus 7,BMIQ7,4p15-p14,
OMIM:605841,Narcolepsy 2 (2),Narcolepsy 2,NRCLP2,4p13-q21,
OMIM:603663,{Mental health wellness-1} (2),Mental health wellness 1,MHW1,4p,
OMIM:601454,{Psoriasis susceptibility 3} (2),Psoriasis susceptibility 3,PSORS3,4q,
OMIM:610430,"{Macroglobulinemia, Waldenstrom, susceptibility to, 2} (2)","Macroglobulinemia, Waldenstrom, susceptibility to, 2",WM2,4q,
OMIM:609258,Myopia 9 (2),Myopia 9,MYP9,4q12,
OMIM:106700,Total anomalous pulmonary venous return (2),Total anomalous pulmonary venous return 1,TAPVR1,4q12,
OMIM:614329,"Mental retardation, autosomal recessive 31 (2)","Mental retardation, autosomal recessive 31",MRT31,4q12-q13.1,
OMIM:612431,"Deafness, autosomal dominant 27 (2)","Deafness, autosomal dominant 27",DFNA27,4q12-q13.1,
OMIM:609952,"Deafness, autosomal recessive 55 (2)","Deafness, autosomal recessive 55",DFNB55,4q12-q13.2,
OMIM:609400,"{Autoimmune disease, susceptibility to, 4} (2)","Autoimmune disease, susceptibility to, 4","AIS4, VAMAS5",4q13-q21,
OMIM:611630,"Epilepsy, familial temporal lobe, 3 (2)","Epilepsy, familial temporal lobe, 3","ETL3, FMTLE",4q13.2-q21.3,
OMIM:613509,Chromosome 4q21 deletion syndrome (4),Chromosome 4q21 deletion syndrome,"DEL4q21, C4DELq21",4q21,
OMIM:608371,Orofacial cleft 4 (2),Orofacial cleft 4,OFC4,4q21-q31,
OMIM:612343,[Musical aptitude QTL 1] (2),Musical aptitude quantitative trait locus 1,MUSQTL1,4q22,
OMIM:609994,Myopia 11 (2),Myopia 11,MYP11,4q22-q27,
OMIM:613518,"{Dermatitis, atopic, susceptibility to, 8} (2)","Dermatitis, atopic, 8",ATOD8,4q22.1,
OMIM:181600,Huriez syndrome (2),Sclerotylosis,"TYS, HRZ",4q23,
OMIM:157300,"{Migraine with or without aura, susceptibility to, 1} (2)","Migraine with or without aura, susceptibility to, 1","MGR1, MA",4q24,
OMIM:615312,"Albinism, oculocutaneous, type V (2)","Albinism, oculocutaneous, type V",OCA5,4q24,
OMIM:613340,"Epilepsy, hot water, 2 (2)","Epilepsy, hot water, 2",HWE2,4q24-q28,
OMIM:611494,"{Atrial fibrillation, familial, 5} (2)","Atrial fibrillation, familial, 5",ATFB5,4q25,
OMIM:152430,[Longevity 1] (2),"Longevity 1, QTL",LGV1,4q25,
OMIM:611598,"{Celiac disease, susceptibility to, 6} (2); {Autoimmune disease, susceptibility to, 5} (2)","Celiac disease, susceptibility to, 6","CELIAC6, AIS5",4q27,
OMIM:612622,"{Diabetes mellitus, insulin-dependent, 23} (2)","Diabetes mellitus, insulin-dependent, 23",IDDM23,4q27,
OMIM:614333,"Mental retardation, autosomal recessive 29 (2)","Mental retardation, autosomal recessive 29",MRT29,4q27-q28.2,
OMIM:111800,"[Blood group, Stoltzfus system] (2)",Stoltzfus blood group,SF,4q28-q31,
OMIM:609782,"Aortic aneurysm, familial abdominal 2 (2)","Aortic aneurysm, familial abdominal 2",AAA2,4q31,
OMIM:605428,"Deafness, autosomal recessive 26 (2)","Deafness, autosomal recessive 26",DFNB26,4q31,
OMIM:612224,{Stature QTL 12} (2),Stature quantitative trait locus 12,STQTL12,4q31,
OMIM:609985,Panic disorder 3 (2),Panic disorder 3,PAND3,4q31-q34,
OMIM:607857,{Psoraisis susceptibility 9} (2),Psoriasis susceptibility 9,PSORS9,4q31-q34,
OMIM:611644,"{Hirschsprung disease, susceptibility to, 9} (2)","Hirschsprung disease, susceptibility to, 9",HSCR9,4q31.3-q32.3,
OMIM:612165,Retinitis pigmentosa 29 (2),Retinitis pigmentosa 29,RP29,4q32-q34,
OMIM:613603,Chromosome 4q32.1-q32.2 triplication syndrome (4),Chromosome 4q32.1-q32.2 triplication syndrome,"TRIP4q32.1q32.2, C4TRIPq32.1q32.2",4q32.1-q32.2,
OMIM:611109,"[Cinnamon odor, pleasantness of] (2)","Cinnamon odor, pleasantness of",CINN,4q32.3,
OMIM:610239,[High density lipoprotein cholesterol level QTL 4] (2),High density lipoprotein cholesterol level QTL 4,HDLCQ4,4q32.3,
OMIM:607258,"Hypercalciuria, absorptive (2)","Hypercalciuria, absorptive, 1",HCA1,4q33-qter,
OMIM:613371,?Spinocerebellar ataxia 30 (2),Spinocerebellar ataxia 30,SCA30,4q34.3-q35.1,
OMIM:600361,Hereditary motor and sensory neuropathy V (2),Hereditary motor and sensory neuropathy V,HMSN5,4q34.3-q35.2,
OMIM:127600,"Dyskeratosis, hereditary benign intraepithelial (2)","Dyskeratosis, hereditary benign intraepithelial",DKBI,4q35,
OMIM:158900,Facioscapulohumeral muscular dystrophy 1 (4),Facioscapulohumeral muscular dystrophy 1,"FSHD1, FSHD1A",4q35,?8(myd)
OMIM:606282,"Deafness, autosomal dominant 24 (2)","Deafness, autosomal dominant 24",DFNA24,4q35-qter,
OMIM:613059,"{Basal cell carcinoma, susceptibility to, 3} (2)","Basal cell carcinoma, susceptibility to, 3",BCC3,5p15.33,
OMIM:613033,{Glioma susceptibility 8} (2),Glioma susceptibility 8,GLM8,5p15.33,
OMIM:612571,{Lung cancer susceptibility 3} (2),Lung cancer susceptibility 3,LNCR3,5p15.33,
OMIM:612554,Myopia 16 (2),Myopia 16,MYP16,5p15.33-p15.2,
OMIM:608850,"Macular dystrophy, retinal, 3 (2)","Macular dystrophy, retinal, 3",MCDR3,5p15.33-p13.1,
OMIM:613608,"Epilepsy, myoclonic, familial adult, 3 (2)","Epilepsy, myoclonic, familial adult, 3","FAME3, FCMTE3",5p15.31-p15.1,
OMIM:606770,"{Adiponectin, serum level of, QTL2} (2)","Adiponectin, serum level of, QTL 2","ADIPQTL2, CAQ5",5p15.2-p14,
OMIM:610213,"Aneurysm, intracranial berry, 4 (2)","Aneurysm, intracranial berry, 4",ANIB4,5p15.2-p14.3,
OMIM:608098,Periventricular nodular heterotopia 3 (2),Periventricular nodular heterotopia 3,PVNH3,5p15.1,
OMIM:613969,Myopia 19 (2),"Myopia 19, autosomal dominant",MYP19,5p15.1-p13.3,
OMIM:613637,[Tuberculin skin test reactivity QTL] (2),Tuberculin skin test reactivity quantitative trait locus,TST2,5p15,
OMIM:607004,"Brachydactyly, type A1, B (2)","Brachydactyly, type A1, locus B",BDA1B,5p13.3-p13.2,
OMIM:612595,"{Multiple sclerosis, susceptibility to, 3} (2)","Multiple sclerosis, susceptibility to, 3",MS3,5p13.2,
OMIM:612262,{Inflammatory bowel disease 18} (2),Inflammatory bowel disease 18,IBD18,5p13.1,
OMIM:608906,"{Attention deficit-hyperactivity disorder}, 143465 (2)","Attention deficit-hyperactivity disorder, susceptibility to, 4",ADHD4,5p13,
OMIM:613174,Chromosome 5p13 duplication syndrome (4),Chromosome 5p13 duplication syndrome,"DUP5p13, C5DUPp13",5p13,
OMIM:610170,Kyphoscoliosis 1 (2),Kyphoscoliosis 1,KYPSC1,5p13,
OMIM:610262,"{Hypertension, essential, susceptibility to, 6}, 145500 (2)","Hypertension, essential, susceptibility to, 6",HYT6,5p13-q12,
OMIM:108800,Atrial septal defect 1 (2),Atrial septal defect 1,ASD1,5p,
OMIM:601888,{Malignant hyperthermia susceptibility 6} (2),Malignant hyperthermia susceptibility 6,MHS6,5p,
OMIM:609657,{Bone size QTL} (2),Bone size quantitative trait locus 2,BSZQTL2,5q,
OMIM:615668,Chromosome 5q12 deletion syndrome (4),Chromosome 5q12 deletion syndrome,"DEL5q12, C5DELq12",5q12,
OMIM:611364,"Myoclonic epilepsy, juvenile, 4 (2)","Myoclonic epilepsy, juvenile, 4",EJM4,5q12-q14,
OMIM:612306,[Thyroid-stimulating hormone level QTL 1] (2),Thyroid-stimulating hormone level QTL 1,TSHQTL1,5q13,
OMIM:607087,"Aortic aneurysm, familial thoracic 2 (2)","Aortic aneurysm, familial thoracic 2","AAT2, FAA2",5q13-q14,
OMIM:605544,"Fibromatosis, gingival, 2 (2)","Fibromatosis, gingival, 2","GINGF2, GGF2, HGF2",5q13-q22,
OMIM:187260,"Telangiectasia, hereditary benign (2)","Telangiectasia, hereditary benign",HBT,5q14,
OMIM:614622,Keratoconus 5 (2),Keratoconus 5,KTCN5,5q14.1-q21.3,
OMIM:614317,Vesicoureteral reflux 4 (2),Vesicoureteral reflux 4,VUR4,5q14.2,
OMIM:612881,Periventricular nodular heterotopia 5 (4),Periventricular nodular heterotopia 5,PVNH5,5q14.3-q15,
OMIM:609570,"{Migraine, susceptibility to, 8} (2)","Migraine, susceptibility to, 8",MGR8,5q21,
OMIM:608970,"Macular dystrophy, butterfly-shaped pigmentary, 2 (2)","Macular dystrophy, butterfly-shaped pigmentary, 2",MDBS2,5q21.3-q33.2,
OMIM:613412,"{Esophagitis, eosinophilic, 2} (2)","Esophagitis, eosinophilic, 2",EOE2,5q22,
OMIM:610535,"Glaucoma 1, open angle, M (2)","Glaucoma 1, open angle, M",GLC1M,5q22.1-q32,
OMIM:181510,"{Schizophrenia}, 181500 (2)","Schizophrenia susceptibility locus, chromosome 5-related",SCZD1,5q23-q35,
OMIM:615649,"Deafness, autosomal dominant 54 (2)","Deafness, autosomal dominant 54",DFNA54,5q31,
OMIM:606348,{Inflammatory bowel disease 5} (2),Inflammatory bowel disease 5,IBD5,5q31,
OMIM:604966,,Protocadherin-alpha gene cluster,PCDHA@,5q31,
OMIM:604967,,Protocadherin-beta gene cluster,PCDHB@,5q31,
OMIM:604968,,Protocadherin-gamma gene cluster,PCDHG,5q31,
OMIM:606263,Paget disease of bone 4 (2),Paget disease of bone 4,PDB4,5q31,
OMIM:615197,{Restless legs syndrome 8} (2),"Restless legs syndrome, susceptibility to, 8",RLS8,5q31,
OMIM:608174,"{Autoimmune thyroid disease, susceptibility to, 2} (2)","Autoimmune thyroid disease, susceptibility to, 2",AITD2,5q31-q33,
OMIM:605845,"{Dermatitis, atopic, susceptibility to, 6} (2)","Dermatitis, atopic, 6",ATOD6,5q31-q33,
OMIM:609754,"{Celiac disease, susceptibility to, 2} (2)","Celiac disease, susceptibility to, 2",CELIAC2,5q31-q33,
OMIM:131400,"Eosinophilia, familial (2)","Eosinophilia, familial",EOS,5q31-q33,
OMIM:248310,"{Malaria, intensity of infection} (2)",Plasmodium falciparum blood infection levels,PFBI,5q31-q33,
OMIM:181460,"{Schistosoma mansoni infection, susceptibility/resistance to} (2)","Schistosoma mansoni infection, susceptibility/resistance to",SM1,5q31-q33,
OMIM:147061,{?Allergy and asthma susceptibility} (2),"Immunoglobulin E concentration, serum",IGES,5q31.1,
OMIM:607683,"Deafness, autosomal dominant 52 (2)","Deafness, autosomal dominant 52","DFNA52, DFNA42",5q31.1-q32,
OMIM:605598,"{Diabetes mellitus, insulin-dependent, 18} (2)",Insulin-dependent diabetes mellitus-18,IDDM18,5q31.1-q33.1,
OMIM:612599,{Psoriasis susceptibility 11} (2),Psoriasis susceptibility 11,PSORS11,5q31.1-q33.1,
OMIM:601101,"Telangiectasia, hereditary hemorrhagic, type 3 (2)","Hereditary hemorrhagic telangiectasia, type 3","HHT3, ORW3",5q31.3-q32,
OMIM:613269,"Corneal dystrophy, Fuchs endothelial, 5 (2)","Corneal dystrophy, Fuchs endothelial, 5","FECD5, FCD3",5q33.1-q35.2,
OMIM:608036,"{Diabetes mellitus, noninsulin-dependent}, 125853 (2)","Diabetes mellitus, noninsulin-dependent, 4",NIDDM4,5q34-q35.2,
OMIM:208100,"Arthrogryposis multiplex congenita, neurogenic (2)","Arthrogryposis multiplex congenital, neurogenic","AMCN, AMCN1",5q35,
OMIM:118840,,Chromate resistance (sulfate transport),CHR,5q35,
OMIM:612886,"{Menopause, natural, age at, QTL4} (2)","Menopause, natural, age at, QTL4",MENOQ4,5q35.2,
OMIM:612582,Chromosome 6pter-p24 deletion syndrome (4),Chromosome 6pter-p24 deletion syndrome,"DEL6pter, C6DELpter",6pter-p24,
OMIM:610294,{Intelligence QTL3} (2),Intelligence quantitative trait locus 3,INTLQ3,6p25.3-p22.3,
OMIM:612558,"{Leukemia, chronic lymphocytic susceptibility to, 4} (2)","Leukemia, chronic lymphocytic susceptibility to, 4",CLLS4,6p25,
OMIM:608545,Larsen-like syndrome (2),Larsen-like syndrome,LRSL,6p25,
OMIM:119530,Orofacial cleft-1 (2),Orofacial cleft-1 (cleft lip with or without cleft palate; isolated cleft palate),"OFC1, CL",6p24.3,
OMIM:607017,"Deafness, autosomal dominant 21 (2)","Deafness, autosomal dominant 21",DFNA21,6p24.1-p22.3,
OMIM:611456,"Tremor, hereditary essential, 3 (2)","Tremor, hereditary essential, 3",ETM3,6p23,
OMIM:600511,"{Schizophrenia}, 181500 (2)","Schizophrenia susceptibility locus, chromosome 6-related",SCZD3,6p23,
OMIM:271250,"Spinocerebellar ataxia, autosomal recessive 3 (2)","Spinocerebellar ataxia, autosomal recessive 3","SCAR3, SCABD",6p23-p21,
OMIM:615192,[Birth weight QTL4] (2),Birth weight quantitative trait locus 4,BWQTL4,6p22.3,
OMIM:613290,"{?Hearing loss, cisplatin-induced, susceptibility to} (2)","Hearing loss, cisplatin-induced, susceptibility to",CIHL,6p22.3,
OMIM:608244,Otosclerosis 3 (2),Otosclerosis 3,OTSC3,6p22.3-p21.3,
OMIM:612892,{Stature QTL 18} (2),Stature quantitative trait locus 18,STQTL18,6p22.1,
OMIM:612368,"{Alkaline phosphatase, plasma level of, QTL3} (2)","Alkaline phosphatase, plasma level of, QTL 3",ALPQTL3,6p22,
OMIM:613015,"{Neuroblastoma, susceptibility to, 4} (2)","Neuroblastoma, susceptibility to, 4",NBLST4,6p22,
OMIM:613024,"{Follicular lymphoma, susceptibility to, 1} (2)","Follicular lymphoma, susceptibility to, 1",FL1,6p21.33,
OMIM:612593,{Lung cancer susceptibility 4} (2),Lung cancer susceptibility 4,LNCR4,6p21.33,
OMIM:612893,{Stature QTL 19} (2),Stature quantitative trait locus 19,STQTL19,6p21.31,
OMIM:612862,"{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to} (2)","Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to",CTEPH1,6p21.3,
OMIM:608645,"Deafness, autosomal dominant 31 (2)","Deafness, autosomal dominant 31",DFNA31,6p21.3,
OMIM:604519,{Inflammatory bowel disease 3} (2),Inflammatory bowel disease 3,IBD3,6p21.3,
OMIM:222100,"{Diabetes mellitus, insulin-dependent-1} (2)",Insulin-dependent diabetes mellitus-1,IDDM1,6p21.3,
OMIM:137100,Immunoglobulin A deficiency (2),Immunoglobulin A deficiency,IGAD1,6p21.3,
OMIM:607085,Myasthenia gravis with thymus hyperplasia (2),Myasthenia gravis with thymus hyperplasia,MYAS1,6p21.3,
OMIM:272370,,Susceptibility to lysis by alloreactive natural killer cells,"NKS1, EC1",6p21.3,17(Hh1)
OMIM:614692,"{?Membranous nephropathy, susceptibility to} (2)","Membranous nephropathy, susceptibility to",MBNP,6p21.3,
OMIM:161550,"{Nasopharyngeal carcinoma, susceptibility to, 2} (2)","Nasopharyngeal carcinoma, susceptibility to, 2",NPCA2,6p21.3,
OMIM:613007,"{Biliary cirrhosis, primary, 2} (2)","Biliary cirrhosis, primary, 2",PBC2,6p21.3,
OMIM:604809,"Panbronchiolitis, diffuse (2)","Panbronchiolitis, diffuse",PBLT,6p21.3,
OMIM:614590,"{Podoconiosis, susceptibility to} (2)","Podoconiosis, susceptibility to",PDCOS,6p21.3,
OMIM:193200,{Vitiligo-associated multiple autoimmune disease susceptibility 6} (2),Vitiligo-associated multiple autoimmune disease susceptibility 6,VAMAS6,6p21.3,
OMIM:608710,Wegener granulomatosis (2),Wegener granulomatosis,WG,6p21.3,
OMIM:153600,"{Macroglobulinemia, Waldenstrom, susceptibility to, 1} (2)","Macroglobulinemia, Waldenstrom, susceptibility to, 1",WM1,6p21.3,
OMIM:150270,?Laryngeal adductor paralysis (2),Laryngeal adductor paralysis,LAP,6p21.3-p21.2,
OMIM:614644,Mean platelet volume QTL4 (2),Mean platelet volume quantitative trait locus 4,MPVQTL4,6p21.3-p21.2,
OMIM:615080,Alzheimer disease 17 (2),Alzheimer disease 17,AD17,6p21.2,
OMIM:132100,Photoparoxysmal response 1 (2),Photoparoxysmal response 1,PPR1,6p21.1,
OMIM:607498,"{Migraine with or without aura, susceptibility to, 3} (2)","Migraine with or without aura, susceptibility to, 3",MGR3,6p21.1-p12.2,
OMIM:608816,"Epilepsy, juvenile myoclonic 3 (2)","Epilepsy, juvenile myoclonic 3",EJM3,6p21,
OMIM:601086,,"Laterality defects, autosomal dominant",LATD,6p21,
OMIM:611185,{Restless legs syndrome 6} (2),"Restless legs syndrome, susceptibility to, 6",RLS6,6p21,
OMIM:614345,"Mental retardation, autosomal recessive 24 (2)","Mental retardation, autosomal recessive 24",MRT24,6p12.2-q12,
OMIM:164100,"Nystagmus 2, congenital, autosomal dominant (2)","Nystagmus 2, congenital, autosomal dominant","NYS2, NYSA",6p12,
OMIM:609026,"{Cataract 28, age-related cortical, susceptibility to} (2)",Cataract 28,"CTRCT28, ARCC1",6p12-q12,
OMIM:608173,"{Autoimmune thyroid disease, susceptibility to, 1} (2)","Autoimmune thyroid disease, susceptibility to, 1",AITD1,6p11,
OMIM:193007,"Vestibulopathy, familial (2)","Vertigo, benign paroxysmal positional",BPPV,6q,
OMIM:613544,Chromosome 6q11-q14 deletion syndrome (4),Chromosome 6q11-q14 deletion syndrome,"DEL6q11q14, C6DELq11q14",6q11-q14,
OMIM:608905,"{Attention deficit-hyperactivity disorder}, 143465 (2)","Attention deficit-hyperactivity disorder, susceptibility to, 2",ADHD3,6q12,
OMIM:614342,"Mental retardation, autosomal recessive 30 (2)","Mental retardation, autosomal recessive 30",MRT30,6q12-q15,
OMIM:605582,"Cardiomyopathy, dilated, 1K (2)","Cardiomyopathy, dilated, 1K",CMD1K,6q12-q16,
OMIM:611572,Otosclerosis 7 (2),Otosclerosis 7,OTSC7,6q13-q16.1,
OMIM:603175,"{Schizophrenia}, 181500 (2)","Schizophrenia susceptibility locus, chromosome 6q-related",SCZD5,6q13-q26,
OMIM:608988,"Atrial fibrillation, familial, 2 (2)","Atrial fibrillation, familial, 2",ATFB2,6q14-q16,
OMIM:600790,"Chorioretinal atrophy, progressive bifocal (2)",Progressive bifocal chorioretinal atrophy,"PBCRA, CRAPB",6q14-q16.2,
OMIM:610685,Split-hand/foot malformation with long bone deficiency 2 (2),Split-hand/foot malformation with long bone deficiency 2,SHFLD2,6q14.1,
OMIM:611944,"Lymphedema, hereditary, IB (2)","Lymphedema, hereditary, IB",LMPH1B,6q16.2-q22.1,
OMIM:613828,"Epilespy, generalized, with febrile seizures plus, type 8 (2)","Generalized epilepsy with febrile seizures plus, type 8",GEFSP8,6q16.3-q22.31,
OMIM:606325,"?Heterotaxy, visceral, 3, autosomal (2)","Heterotaxy, visceral, 3, autosomal",HTX3,6q21,
OMIM:601666,"{Diabetes mellitus, insulin-dependent, 15} (2)",Insulin-dependent diabetes mellitus-15,IDDM15,6q21,
OMIM:606460,[Longevity 2] (2),Longevity 2,LGV2,6q21,
OMIM:601349,"Microphthalmia, syndromic 8 (2)","Microphthalmia, syndromic 8","MCOPS8, MMEP",6q21,
OMIM:612882,"{Menarche, age at, QTL2} (2)","Menarche, age at, QTL2",MENAQ2,6q21,
OMIM:608852,{Pulmonary function} (2),Pulmonary function,PLF,6q21-q22,
OMIM:161950,"{IgA nephropathy, susceptibility to, 1} (2)","IgA nephropathy, susceptibility to, 1",IGAN1,6q22-q23,
OMIM:604201,{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection} (2),Hepatic fibrosis susceptibility due to Schistosoma mansoni infection,SM2,6q22-q23,
OMIM:609255,"Febrile seizures, familial, 5 (2)","Febrile seizures, familial, 5",Feb5,6q22-q24,
OMIM:606035,[Fasting insulin level quantitative trait locus 1] (2),Fasting insulin level quantitative trait locus 1,FIQTL1,6q22-q24,
OMIM:142470,Fetal hemoglobin quantitative trait locus 2 (2),Fetal hemoglobin quantitative trait locus 2,"HBFQTL2, FCP",6q22.3-q23.1,
OMIM:609319,[Hematocrit/hemoglobin quantitative trait locus 1] (2),Hematocrit/hemoglobin quantitative trait locus 1,HCHGQ1,6q23,
OMIM:614494,Retinitis pigmentosa 63 (2),Retinitis pigmentosa 63,RP63,6q23,
OMIM:180300,"{Rheumatoid arthritis, susceptibility to} (2)","Rheumatoid arthritis, susceptibility to",RA,6q23,
OMIM:612378,"{Systemic lupus erythematosus, susceptibility to, 13} (2)","Systemic lupus erythematosus, susceptibility to, 13",SLEB13,6q23,
OMIM:611536,{Major affective disorder 6} (2),Major affective disorder 6,"MAFD6, BPAD",6q23-q24,
OMIM:608220,"Spastic paraplegia 25, autosomal recessive (2)","Spastic paraplegia 25, autosomal recessive, with disc herniation",SPG25,6q23-q24.1,
OMIM:607446,[Body mass index QTL3] (2),Body mass index quantitative trait locus 3,BMIQ3,6q23-q25,
OMIM:608935,{Lung cancer susceptibility} (2),Lung cancer 1,LNCR1,6q23-q25,
OMIM:614645,Mean platelet volume QTL5 (2),Mean platelet volume quantitative trait locus 5,MPVQTL5,6q23.3,
OMIM:612863,Chromosome 6q25-q25 deletion syndrome (4),Chromosome 6q24-q25 deletion syndrome,"DEL6q24q25, C6DELq25q25",6q24-q25,
OMIM:606255,{Stature QTL 1} (2),Stature quantitative trait locus 1,STQTL1,6q24-q25,
OMIM:127500,Dyschromatosis universalis hereditaria 1 (2),Dyschromatosis universalis hereditaria 1,"DUH1, DUH",6q24.2-q25.2,
OMIM:612114,[Bone mineral density QTL 11] (2),Bone mineral density quantitative trait locus 11,BMND11,6q25,
OMIM:612521,"{Diabetes mellitus, insulin-dependent, 21} (2)","Diabetes mellitus, insulin-dependent, 21",IDDM21,6q25,
OMIM:180020,?Retinal cone dystrophy-1 (2),Retinal cone dystrophy-1,RCD1,6q25-q26,
OMIM:600883,"{Diabetes mellitus, insulin-dependent, 8} (2)",Insulin-dependent diabetes mellitus-8,IDDM8,6q25-q27,
OMIM:612010,"{Celiac disease, susceptibility to, 12} (2)","Celiac disease, susceptibility to, 12",CELIAC12,6q25.3,
OMIM:608219,"Deafness, autosomal recessive 38 (2)","Deafness, autosomal recessive 38",DFNB38,6q26-q27,
OMIM:614347,"Mental retardation, autosomal recessive 28 (2)","Mental retardation, autosomal recessive 28",MRT28,6q26-q27,
OMIM:611382,"{Kala-azar, susceptibility to, 3} (2)","Kala-azar, susceptibility to, 3",KAZA3,6q27,
OMIM:614238,Hypotrichosis 10 (2),Hypotrichosis 10,HYPT10,7p22.3-p21.3,
OMIM:185100,"{Strabismus, susceptibility to, 1} (2)","Strabismus, susceptibility to, 1",STBMS1,7p22.1,
OMIM:605635,"Hyperaldosteronism, familial, type II (2)","Hyperaldosteronism, familial, type II",FHII,7p22,
OMIM:614021,"Ventricular tachycardia, catecholaminergic polymorphic, 3 (2)","Ventricular tachycardia, catecholaminergic polymorphic, 3",CPVT3,7p22-p14,
OMIM:613462,[Fasting plasma glucose level QTL 4] (2),Fasting plasma glucose level QTL 4,FGQTL4,7p21.2,
OMIM:613576,Ectodermal dysplasia-syndactyly syndrome 2 (2),Ectodermal dysplasia-syndactyly syndrome 2,EDSS2,7p21.2-p14.3,
OMIM:153880,"Macular dystrophy, dominant cystoid (2)","Macular dystrophy, dominant cystoid",MDDC,7p21-p15,
OMIM:608367,Myopia 17 (2),Myopia 17,"MYP17, MYP4",7p15,
OMIM:612737,{Stature QTL 17} (2),Stature quantitative trait locus 17,STQTL17,7p15,
OMIM:613219,[Fasting plasma glucose level QTL 2] (2); [Birth weight QTL 1] (2),Fasting plasma glucose level QTL 2; Birth weight QTL 1,"FGQTL2, BWQTL1",7p15-p13,
OMIM:610655,"Telangiectasia, hereditary hemorrhagic, type 4 (2)","Telangiectasia, hereditary hemorrhagic, type 4",HHT4,7p14,
OMIM:613067,"{Leukemia, acute lymphoblastic, susceptibility to, 2} (2)","Leukemia, acute lymphoblastic, susceptibility to, 2",ALL2,7p12.2,
OMIM:614676,"Cardiomyopathy, hypertrophic, 21 (2)","Cardiomyopathy, familial hypertrophic, 21",CMH21,7p12.1-q21,
OMIM:608345,"Nystagmus 3, congenital, autosomal dominant (2)","Nystagmus 3, congenital, autosomal dominant",NYS3,7p11.2,
OMIM:180860,Silver-Russell syndrome (4),Silver-Russell syndrome,"SRS, RSS",7p11.2,
OMIM:252270,Myelodysplasia and leukemia syndrome with monosomy 7 (4),Monosomy 7 of bone marrow,"MLSM7, DEL7q, C7DELq",7q,
OMIM:608658,"{Prostate cancer, susceptibility to, 4}, 176807 (2)","Prostate cancer, hereditary, 4",HPC4,7p11-q21,
OMIM:105800,"Aneurysm, intracranial berry, 1 (2)","Aneurysm, intracranial berry, 1",ANIB1,7q11.2,
OMIM:610247,"{Esophagitis, eosinophilic, 1} (2)","Esophagitis, eosinophilic, 1","EOE1, EE",7q11.2,
OMIM:129900,?EEC syndrome-1 (2),"Ectrodactyly, ectodermal dysplasia, cleft lip/palate, 1",EEC1,7q11.2-q21.3,
OMIM:613729,"Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)","Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb","DEL7q11.23, C7DELq11.23",7q11.23,
OMIM:609757,Chromosome 7q11.23 duplication syndrome (4),Chromosome 7q11.23 duplication syndrome,"DUP7q11.23, C7DUPq11.23",7q11.23,
OMIM:194050,Williams-Beuren syndrome (4),Williams-Beuren syndrome (chromosome 7q11.23 deletion syndrome),"WBS, WMS, WS, DEL7q11, C7DELq11",7q11.23,
OMIM:612223,{Stature QTL 11} (2),Stature quantitative trait locus 11,STQTL11,7q21,
OMIM:154276,{Malignant hyperthermia susceptibility 3} (2),Malignant hyperthermia susceptibility 3,MHS3,7q21-q22,
OMIM:183600,Split hand/foot malformation 1 (4),Split hand/foot malformation (ectrodactyly) type 1,"SHFM1, SHFD1, SHSF1",7q21.2-q21.3,
OMIM:209850,{Autism susceptibility 1} (2),"Autism, susceptibility to, 1",AUTS1,7q22,
OMIM:191390,{Inflammatory bowel disease 11} (2),Inflammatory bowel disease 11,IBD11,7q22,
OMIM:608562,"Polydactyly, postaxial, type A4 (2)","Polydactyly, postaxial, type A4",PAPA4,7q22,
OMIM:607458,Spinocerebellar ataxia 18 (2),Spinal cerebellar ataxia 18,"SCA18, SMNA",7q22-q32,
OMIM:162820,"?Neutrophil chemotactic response, abnormal (2)","Neutrophil migration, abnormal","NM, NCR",7q22-qter,
OMIM:614646,Mean platelet volume QTL6 (2),Mean platelet volume quantitative trait locus 6,MPVQTL6,7q22.3,
OMIM:609915,"Cardiomyopathy, dilated, 1Q (2)","Cardiomyopathy, dilated, 1Q",CMD1Q,7q22.3-q31.1,
OMIM:611015,"{Autism, susceptibility to, 9} (2)","Autism, susceptibility to, 9",AUTS9,7q31,
OMIM:603678,"Deafness, autosomal recessive 14 (2)","Deafness, autosomal recessive 14",DFNB14,7q31,
OMIM:603010,"Deafness, autosomal recessive 17 (2)","Deafness, autosomal recessive 17",DFNB17,7q31,
OMIM:606256,{Stature QTL 2} (2),Stature quantitative trait locus 2,STQTL2,7q31.3,
OMIM:613063,"{Basal cell carcinoma, susceptibility to, 6} (2)","Basal cell carcinoma, susceptibility to, 6",BCC6,7q32,
OMIM:614220,"Biliary cirrhosis, primary, 4 (2)","Biliary cirrhosis, primary, 4",PBC4,7q32,
OMIM:609573,Photoparoxysmal response 3 (2),Photoparoxysmal response 3,PPR3,7q32,
OMIM:613909,Spinocerebellar ataxia 32 (2),Spinocerebellar ataxia 32,SCA32,7q32-q33,
OMIM:146450,"Hypospadias 3, autosomal (2)","Hypospadias 3, autosomal",HYSP3,7q32.2-q36.1,
OMIM:606641,[Body mass index QTL1] (2),Body mass index quantitative trait locus 1,BMIQ1,7q32.3,
OMIM:215400,"{Chordoma, susceptibility to} (4)",Chordoma,CHDM,7q33,
OMIM:182960,"Neuronopathy, distal hereditary motor, type I (2)","Neuronopathy, distal hereditary motor, type I",DHMN1,7q34-q36,
OMIM:603098,"Deafness, autosomal recessive 13 (2)","Deafness, autosomal recessive 13",DFNB13,7q34-q36,
OMIM:605727,Otosclerosis 2 (2),Otosclerosis 2,OTSC2,7q34-q36,
OMIM:600510,Pigment dispersion syndrome (2),Glaucoma-related pigment dispersion syndrome-1,"GPDS1, PDS1",7q35-q36,
OMIM:612514,{Specific language impairment 4} (2),Specific language impairment 4,SLI4,7q35-q36,
OMIM:605967,Acropectoral syndrome (2),Acropectoral syndrome,ACRPS,7q36,
OMIM:609636,"Alzheimer disease-10, 104300 (2)",Alzheimer disease-10,AD10,7q36,
OMIM:611016,"{Autism, susceptibility to, 10} (2)","Autism, susceptibility to, 10",AUTS10,7q36,
OMIM:613959,Schizophrenia 16 (4),"Chromosome 7q36.3 duplication syndrome, 362kb","SCZD16, C16DUPq36.3, DUP7q36.3",7q36.3,
OMIM:608391,"{Autoimmune disease, susceptibility to, 2} (2)","Autoimmune disease, susceptibility to, 2","AIS2, VAMAS3",Chr.7,
OMIM:606129,Diamond-Blackfan anemia 2 (2),Diamond-Blackfan anemia 2,DBA2,8p23.3-p22,
OMIM:222400,"Hernia, congenital diaphragmatic 2 (2)","Hernia, congenital diaphragmatic 2",DIH2,8p23.1,
OMIM:612254,"{Systemic lupus erythematosus, susceptibility to, 12} (2)","Systemic lupus erythematosus, susceptibility to, 12",SLEB12,8p23.1,
OMIM:609259,Myopia 10 (2),Myopia 10,MYP10,8p23,
OMIM:606662,"Waardenburg syndrome, type 2C (2)","Waardenburg syndrome, type 2C",WS2C,8p23,
OMIM:148370,Keratolytic winter erythema (2),Keratolytic winter erythema,KWE,8p23-p22,
OMIM:612279,"Epilepsy, generalized, with febrile seizures plus, type 6 (2)","Generalized epilepsy with febrile seizures plus, type 6",GEFSP6,8p23-p21,
OMIM:614252,"Aneurysm, intracranial berry, 11 (2)","Aneurysm, intracranial berry, 11",ANIB11,8p22,
OMIM:612030,"{Coronary heart disease, susceptibility to, 9} (2)","Coronary heart disease, susceptibility to, 9",CHDS9,8p22,
OMIM:612789,"Deafness, autosomal recessive 71 (2)","Deafness, autosomal recessive 71",DFNB71,8p22-p21.3,
OMIM:610099,"Myopathy, distal 3 (2)","Myopathy, distal 3",MPD3,8p22-q11,
OMIM:611945,"Spastic paraplegia 37, autosomal dominant (2)",Spastic paraplegia 37,SPG37,8p21.1-q13.3,
OMIM:609649,Trichilemmal cyst 1 (2),Trichilemmal cyst 1,TRICY1,3p24-p21.2,
OMIM:603013,"{Schizophrenia}, 181500 (2)","Schizophrenia susceptibility locus, chromosome 8p-related",SCZD6,8p21,
OMIM:612348,?Thrombophilia due to decreased release of tissue plasminogen (1),Thrombophilia due to decreased release of tissue plasminogen activator,THPH9,8p12,
OMIM:611073,{Alzheimer disease 12} (2),Alzheimer disease 12,AD12,8p12-q22,
OMIM:613523,Chromosome 8p11 myeloproliferative syndrome (4),Chromosome 8p11 myeloproliferative syndrome (stem cell leukemia/lymphoma),SCLL,8p11,
OMIM:600668,Chondrocalcinosis with early-onset osteoarthritis (2),Chondrocalcinosis 1,CCAL1,8q,
OMIM:606789,Fetal hemoglobin quantitative trait locus 4 (2),Fetal hemoglobin quantitative trait locus 4,HBFQTL4,8q,
OMIM:609197,Glucocorticoid deficiency 3 (2),Glucocorticoid deficiency 3,"GCCD3, FGD3, GCCD2",8q11.2-q13.2,
OMIM:128700,"?Preauricular fistulae, congenital (2)","Preauricular fistulae, congenital",PAFC,8q11.1-q13.3,
OMIM:608765,"{Scoliosis, isolated, susceptibility to, 3} (2)","Scoliosis, isolated, susceptibility to, 3",IS3,8q12,
OMIM:611046,"{Mycobacterium tuberculosis, susceptibility to, 2} (2)","Mycobacterium tuberculosis, susceptibility to, 2",MTBS2,8q12-q13,
OMIM:612587,"{Aneurysm, intracranial berry, 10} (2)","Aneurysm, intracranial berry, 10",ANIB10,8q12.1,
OMIM:600257,Bor-Duane hydrocephalus contiguous gene syndrome (4),Bor-Duane hydrocephalus contiguous gene syndrome (chromosome 8q12.1-q21.2 deletion syndrome),"DEL8q12q21, C8DELq12q21",8q12.2-q21.2,
OMIM:123155,"?Hydrocephalus, autosomal dominant (2)","Hydrocephalus, autosomal dominant",HDCPH1,8q12.2-q21.2,
OMIM:600383,Mesomelia-synostoses syndrome (4),Mesomelia-synostoses syndrome (Chromosome 8q13 deletion syndrome),"DEL8q13, C8DELq13",8q13,
OMIM:126800,Duane retraction syndrome 1 (2),Duane retraction syndrome 1,"DURS1, DUS",8q13,
OMIM:121210,"Febrile seizures, familial, 1 (2)","Febrile seizures, familial, 1",Feb1,8q13-q21,
OMIM:607731,"Charcot-Marie-Tooth disease, axonal, type 2H (2)","Charcot-Marie-Tooth disease, axonal, type 2H",CMT2H,8q13-q23,
OMIM:258500,Optic atrophy 6 (2),Optic atrophy 6,OPA6,8q21-q22,
OMIM:614230,Chromosome 8q21.11 deletion syndrome (4),Chromosome 8q21.11 deletion syndrome,"DEL8q21.11, C8DELq21.11",8q21.11,
OMIM:612578,{Stature QTL 15} (2),Stature quantitative trait locus 15,STQTL15,8q21.13,
OMIM:145701,"?Hypertrichosis universalis congenita, Ambras type (2)","Hypertrichosis universalis congenita, Ambras type",HTC1,8q22,
OMIM:151200,Leri pleonosteosis chromosome duplication syndrome (4),Chromosome 8q22.1 duplication syndrome (Leri pleonosteosis),"DUP8q22.1, C8DUPq22.1",8q22.1,
OMIM:608156,Nablus mask-like facial syndrome (4),Nablus mask-like facial syndrome (chromosome 8q22.1 deletion syndrome),"NMLFS, DEL8q22.1, C8DELq22.1",8q22.1,
OMIM:149000,Klippel-Trenaunay-Weber syndrome (2),Klippel-Trenaunay-Weber syndrome,"KTWS, KTS",8q22.3,
OMIM:613318,Miyoshi muscular dystrophy 2 (2),Miyoshi muscular dystrophy 2,MMD2,8q22.3,
OMIM:612231,"{Colorectal cancer, susceptibility to, 6} (2)","Colorectal cancer, susceptibility to, 6",CRCS6,8q23,
OMIM:602429,"Glaucoma 1D, primary open angle (2)","Glaucoma 1, open angle, D",GLC1D,8q23,
OMIM:607053,[High density lipoprotein cholesterol level QTL 2] (2),High density lipoprotein cholesterol level QTL 2,HDLCQ2,8q23,
OMIM:612729,[Lean body mass QTL 1] (2),Lean body mass quantitative trait locus 1,LBMQTL1,8q23,
OMIM:608796,Moyamoya disease 3 (2),Moyamoya disease 3,MYMY3,8q23,
OMIM:140300,Hashimoto thyroiditis (2),Hashimoto thyroiditis,HT,8q23-q24,
OMIM:611376,Mungan syndrome (2),Mungan syndrome,MGS,8q23-q24,
OMIM:610649,[Bone size quantitative trait locus 3] (2),Bone size quantitative trait locus 3,BSZQTL3,8q24,
OMIM:611469,"{Colorectal cancer, susceptibility to, 2} (2)","Colorectal cancer, susceptibility to, 2",CRCS2,8q24,
OMIM:600131,"Epilepsy, childhood absence, 1 (2)","Epilepsy, childhood absence, 1",ECA1,8q24,
OMIM:600669,"{Epilepsy, idiopathic generalized, susceptibility to, 1} (2)","Epilespy, idiopathic generalized, susceptibility to 1",EIG1,8q24,
OMIM:611100,"{Prostate cancer, hereditary, 10} (2)","Prostate cancer, hereditary, 10",HPC10,8q24,
OMIM:601068,"Epilepsy, myoclonic, familial adult, 1 (2)","Epilepsy, myoclonic, adult familial, 1","FAME1, BAFME1, MEBA",8q24,
OMIM:150230,"Trichorhinophalangeal syndrome, type II (4)","Trichorhinophalangeal syndrome, type II (Langer-Giedion syndrome)","TRPS2, LGCR, LGS",8q24.11-q24.13,
OMIM:614936,"Keratoderma, palmoplantar, punctate type IB (2)","Keratoderma, palmoplantar, punctate type IB",PPKP1B,8q24.13-q24.21,
OMIM:612448,{Age-related hearing impairment 1} (2),Age-related hearing impairment 1,ARHI1,8q24.13-q24.22,
OMIM:613032,{Glioma susceptibility 7} (2),Glioma susceptibility 7,GLM7,8q24.21,
OMIM:612858,Orofacial cleft 12 (2),Orofacial cleft 12,OFC12,8q24.3,
OMIM:608392,"{Autoimmune disease, susceptibility to, 3} (2)","Autoimmune disease, susceptibility to, 3","AIS3, VAMAS4",Chr.8,
OMIM:154230,46XY sex reversal 4 (4),Chromosome 9p24.3 deletion syndrome,"DEL9p24.3, C9DELp24.3, SRXY4",9p24.3,
OMIM:613271,"Corneal dystrophy, Fuchs endothelial, 7 (2)","Corneal dystrophy, Fuchs endothelial, 7","FECD7, FCD4",9p24.1-p22.1,
OMIM:614113,"Mental retardation, autosomal dominant 2 (4)","Mental retardation, autosomal dominant 2",MRD2,9p24,
OMIM:610438,{Restless legs syndrome 3} (2),"Restless legs syndrome, susceptibility to, 3",RLS3,9p24-p22,
OMIM:614208,"Mental retardation, autosomal recessive 16 (2)","Mental retardation, autosomal recessive 16",MRT16,9p23-p13.3,
OMIM:601992,Friedreich ataxia 2 (2),Friedreich ataxia 2,FRDA2,9p23-p11,
OMIM:613685,"Deafness, autosomal recessive 83 (2)","Deafness, autosomal recessive 83",DFNB83,9p23-p21.2,
OMIM:609790,Alzheimer disease-11 (2),Alzheimer disease 11,AD11,9p22.1,
OMIM:608652,"Deafness, autosomal dominant 47 (2)","Deafness, autosomal dominant 47","DFNA47, DFNB83",9p22-p21,
OMIM:611891,"{Aneurysm, familial abdominal 3} (2)","Aneurysm, familial abdominal 3",AAA3,9p21,
OMIM:611892,"{Aneurysm, intracranial berry, 6} (2)","Aneurysm, intracranial berry, 6",ANIB6,9p21,
OMIM:613062,"{Basal cell carcinoma, susceptibility to, 5} (2)","Basal cell carcinoma, susceptibility to, 5",BCC5,9p21,
OMIM:611139,"{Coronary heart disease, susceptibility to, 8} (2)","Coronary heart disease, susceptibility to, 8",CHDS8,9p21,
OMIM:612099,"Trichoepithelioma, multiple familial, 2 (2)","Trichoepithelioma, multiple familial, 2","MFT2, TEM",9p21,
OMIM:613030,{Glioma susceptibility 5} (2),Glioma susceptibility 5,GLM5,9p21.3,
OMIM:612096,Otosclerosis 8 (2),Otosclerosis 8,OTSC8,9p13.1-q21.11,
OMIM:609403,Preeclampsia/eclampsia 3 (2),Preeclampsia/eclampsia 3,PEE3,9p13,
OMIM:605388,"Cerebral palsy, ataxic, autosomal recessive (2)","Cerebral palsy, ataxic, autosomal recessive",ACP,9p12-q12,
OMIM:155900,?Melkersson-Rosenthal syndrome (2),Melkersson-Rosenthal syndrome,MROS,9p11,
OMIM:158170,Chromosome 9p deletion syndrome (4),Chromosome 9p deletion syndrome,"DEL9p, C9DELp",9p,
OMIM:606613,[High density lipoprotein cholesterol level QTL 1] (2),High density lipoprotein cholesterol level QTL 1,HDLCQ1,9p,
OMIM:609320,[Hematocrit/hemoglobin quantitative trait locus 2] (2),Hematocrit/hemoglobin quantitative trait locus 2,HCHGQ2,9q,
OMIM:607152,"Spastic paraplegia 19, autosomal dominant (2)",Spastic paraplegia-19,SPG19,9q,
OMIM:600884,"Cardiomyopathy, dilated 1B (2)","Cardiomyopathy, dilated-1B, autosomal dominant","CMD1B, CMPD1, FDC",9q13,
OMIM:190100,Geniospasm (2),Geniospasm 1,"GSM1, GSP",9q13-q21,
OMIM:605749,"Cataract 26, multiple types (2)","Cataract 26, multiple types","CTRCT26, CAAR",9q13-q22,
OMIM:613088,"{Pelvic organ prolapse, susceptibility to, 2} (2)","Pelvic organ prolapse, susceptibility to, 2",PVOP2,9q21,
OMIM:611631,"Epilepsy, familial temporal lobe, 4 (2)","Epilepsy, familial temporal lobe, 4","ETL4, ETOLM",9q21-q22,
OMIM:613558,"Deafness, autosomal dominant 51 (4)","Deafness, autosomal dominant 51 (chromosome 9q21.11 duplication syndrome)","DFNA51, C9DUPq21.11, DUP9q21.11",9q21.11,
OMIM:267700,"Hemophagocytic lymphohistiocytosis, familial, 1 (2)","Hemophagocytic lymphohistiocytosis, familial, 1","FHL1, HPLH1, HLH1",9q21.3-q22,
OMIM:608695,"Glaucoma, primary open angle, juvenile-onset, 2 (2)","Glaucoma, primary open angle, juvenile-onset, 2",JOAG2,9q22,
OMIM:610114,{Stature QTL 8} (2),Stature quantitative trait locus 8,STQTL8,9q22,
OMIM:600156,"{Hirschsprung disease, susceptibility to, 5} (2)","Hirschsprung disease, susceptibility to, 5",HSCR5,9q31,
OMIM:607853,Panic disorder 2 (2),Panic disorder 2,PAND2,9q31,
OMIM:608026,Hypertensive nephropathy (2),Hypertensive nephropathy,HNP1,9q31-q32,
OMIM:183840,"{Spondyloarthropathy, susceptibility to, 2} (2)","Spondyloarthropathy, susceptibility to, 2",SPDA2,9q31-q34,
OMIM:614954,"Congenital heart defects, multiple types, 3 (2)","Congenital heart defects, multiple types, 3",CHDT3,9q31.1,
OMIM:612883,"{Menarche, age at, QTL3} (2)","Menarche, age at, QTL3",MENAQ3,9q31.2,
OMIM:612238,"{Scoliosis, idiopathic, susceptibility to, 4} (2)","Scoliosis, idiopathic, susceptibility to, 4",IS4,9q31.2-q34.2,
OMIM:612259,{Inflammatory bowel disease 16} (2),"Inflammatory bowel disease 16, susceptibility to",IBD16,9q32,
OMIM:608762,"{Epilepsy, idiopathic generalized, susceptibility to, 3} (2)","Epilepsy, idiopathic generalized, susceptibility to 3",EIG3,9q32-q33,
OMIM:613207,"{Asthma-related traits, susceptibility to, 8} (2)","Asthma-related traits, susceptibility to, 8",ASRT8,9q33,
OMIM:612113,[Bone mineral density QTL 10] (2),Bone mineral density quantitative trait locus 10,BMND10,8q24,
OMIM:614623,Keratoconus 6 (2),Keratoconus 6,KTCN6,9q34,
OMIM:612557,"{Leukemia, chronic lymphocytic, susceptibility to, 3} (2)","Leukemia, chronic lymphocytic, susceptibility to, 3",CLLS3,9q34.1,
OMIM:171720,"{Alkaline phosphatase, plasma level of, QTL1} (2)","Alkaline phosphatase, plasma level of, QTL 1",ALPQTL1,9q34.13,
OMIM:612594,"{Multiple sclerosis, susceptibility to, 2} (2)","Multiple sclerosis, susceptibility to, 2",MS2,10p15.1,
OMIM:611384,{Plasmodium falciparum fever episodes QTL1} (2),Plasmodium falciparum fever episodes QTL1,PFFE1,10p15,
OMIM:612230,"{Colorectal cancer, susceptibility to, 5} (2)","Colorectal cancer, susceptibility to, 5",CRCS5,10p14,
OMIM:601362,DiGeorge syndrome/velocardiofacial syndrome complex-2 (2),DiGeorge syndrome chromosome region-2,"DGCR2, DGS2",10p14-p13,
OMIM:604401,Arrhythmogenic right ventricular dysplasia 6 (2),Arrhythmogenic right ventricular dysplasia 6,ARVD6,10p14-p12,
OMIM:606187,Alzheimer disease-7 (2),Alzheimer disease 7,AD7,10p13,
OMIM:609888,"{Leprosy, paucibacillary type, susceptibility to} (2)","Leprosy, paucibacillary type, susceptibility to",LPRS,10p13,
OMIM:607239,"Deafness, autosomal recessive 33 (2)","Deafness, autosomal recessive 33",DFNB33,10p11.23-q21.1,
OMIM:611934,"{Epilepsy, idiopathic generalized, susceptibility to, 5} (2)","Epilepsy, idiopathic generalized, susceptibility to, 5",EIG5,10p11.22,
OMIM:614990,"Usher syndrome, type IK (2)","Usher syndrome, type IK",USH1K,10p11.21-q21.1,
OMIM:607499,"{Bulimia nervosa, susceptibility to} (2)","Bulimia nervosa, susceptibility to",BULN,10p,
OMIM:603188,"{Obesity, susceptibility to, BMIQ8} (2)",Body mass index quantitative trait locus 8,BMIQ8,10p,
OMIM:608176,"{Autoimmune thyroid disease, susceptibility to, 4} (2)","Autoimmune thyroid disease, susceptibility to, 4",AITD4,10q,
OMIM:610926,"Tooth agenesis, selective, 5 (2)","Tooth agenesis, selective, 5",STHAG5,10q11.2-q21,
OMIM:614237,Hypotrichosis 9 (2),Hypotrichosis 9,HYPT9,10q11.23-q22.3,
OMIM:613065,"{Leukemia, acute lymphocytic, susceptibility to, 1} (2)","Leukemia, acute lymphocytic, susceptibility to, 1",ALL1,10q21,
OMIM:612369,"{Alkaline phosphatase, plasma level of, QTL4} (2)","Alkaline phosphatase, plasma level of, QTL 4",ALPQTL4,10q21,
OMIM:612255,{Inflammatory bowel disease 15} (2),Inflammatory bowel disease 15,IBD15,10q21,
OMIM:612357,"{Major affective disorder-8, susceptibility to} (2)",Major affective disorder 8,MAFD8,10q21,
OMIM:612717,Myopia 15 (2),Myopia 15,MYP15,10q21.1,
OMIM:604185,"Facial paresis, hereditary congenital, 2 (2)","Facial paresis, hereditary congenital, 2",HCFP2,10q21.3-q22.1,
OMIM:613339,"Epilepsy, hot water, 1 (2)","Epilepsy, hot water, 1",HWE1,10q21.3-q22.3,
OMIM:611094,"Mental retardation, autosomal recessive, 8 (2)","Mental retardation, autosomal recessive, 8",MRT8,10q22,
OMIM:611003,{Smoking as a quantitative trait locus 1} (2),Smoking as a quantitative trait locus 1,SQTL1,10q22,
OMIM:611706,"{Migraine, with or without aura, susceptibility to, 12} (2)","Migraine, with or without aura, susceptibility to, 12",MGR12,10q22-q23,
OMIM:608583,"Atrial fibrillation, familial, 1 (2)","Atrial fibrillation, familial, 1",ATFB1,10q22-q24,
OMIM:609041,"Spastic paraplegia 27, autosomal recessive (2)","Spastic paraplegia-27, autosomal recessive",SPG27,10q22.1-q24.1,
OMIM:608078,"{Schizophrenia}, 181500 (2)","Schizophrenia susceptibility locus, chromosome 10q-related",SCZD11,10q22.3,
OMIM:607965,"{Systemic lupus erythematosus with nephritis, susceptibility to, 1} (2)","Systemic lupus erythematosus with nephritis, susceptibility to, 1",SLEN1,10q22.3,
OMIM:612388,"{Sarcoidosis, susceptibility to, 3} (2)","Sarcoidosis, susceptibility to, 3",SS3,10q22.3,
OMIM:612242,Chromosome 10q22.3-q23.2 deletion syndrome (4),Chromosome 10q22.3-q23.2 deletion syndrome,"DEL10q23, C10DELq23",10q23,
OMIM:611920,[C-reactive protein QTL] (2),C-reactive protein QTL,CPROTQ,10q23-q24,
OMIM:612288,{Inflammatory bowel disease 20} (2),Inflammatory bowel disease 20,IBD20,10q23-q24,
OMIM:609578,"Cardiomyopathy, familial restrictive, 2 (2)","Cardiomyopathy, familial restrictive, 2",RCM2,10q23.3,
OMIM:613006,"{Diabetes mellitus, insulin-dependent, 24} (2)","Diabetes mellitus, insulin-dependent, 24",IDDM24,10q23.31,
OMIM:605526,"Alzheimer disease 6, 104300 (2)",Alzheimer disease 6,AD6,10q24,
OMIM:246560,"Split-hand/foot malformation 3, gene duplication syndrome (4)",Split-hand/foot malformation 3 (Chromosome 10q24 duplication syndrome),"SHFM3, SHSF3, DUP10q24, C10DUPq24",10q24,
OMIM:606483,"Charcot-Marie-Tooth disease, dominant intermediate A (2)","Charcot-Marie-Tooth disease, dominant intermediate A",CMTDIA,10q24.1-q25.1,
OMIM:614927,"Ectodermal dysplasia 5, hair/nail type (2)","Ectodermal dysplasia 5, hair/nail type",ECTD5,10q24.32-q25.1,
OMIM:603266,"{Diabetes mellitus, insulin-dependent, 17} (2)",Insulin-dependent diabetes mellitus-17,IDDM17,10q25,
OMIM:609750,"{Epilepsy, idiopathic generalized, susceptibility to 4} (2)","Epilepsy, idiopathic generalized, susceptibility to 4",EIG4,10q25-q26,
OMIM:615163,Cone-rod dystrophy 17 (2),Cone-rod dystrophy 17,CORD17,10q26,
OMIM:609625,Chromosome 10q26 deletion syndrome (4),Chromosome 10q26 deletion syndrome,"DEL10q26, C10q26DEL",10q26,
OMIM:131200,"{Endometriosis, susceptibility to, 1} (2)","Endometriosis, susceptibility to, 1",ENDO1,10q26,
OMIM:609116,[Respiratory rhythmicity in sleep] (2),Respiratory rhythmicity in sleep,RRIS,10q26,
OMIM:166760,"{Otitis media, susceptibility to} (2)",Otitis media susceptibility to,OMS,10q26.3,
OMIM:607967,"{Systemic lupus erythematosus with nephritis, susceptibility to, 3} (2)","Systemic lupus erythematosus with nephritis, susceptibility to, 3",SLEN3,11p15.5,
OMIM:611010,"Fibromatosis, gingival, 4 (2)","Fibromatosis, gingival, 4","GINGF4, HGF4, GGF4",11p15,
OMIM:235000,Hemihypertrophy (2),"Hemihyperplasia, isolated","IH, HHP",11p15,
OMIM:609470,Left ventricular noncompaction 2 (2),Left ventricular noncompaction 2,LVNC2,11p15,
OMIM:616792,"{Neuroblastoma, susceptibility to, 7} (2)","Neuroblastoma, susceptiblity to, 7",NBLST7,11p15,
OMIM:606528,Chromosome 11p15-p14 deletion syndrome (4),Chromosome 11p15-p14 deletion syndrome (homozygous),"DEL11p15p14, C11DELp15p14",11p15-p14,
OMIM:612642,"Deafness, autosomal dominant 59 (2)","Deafness, autosomal dominant 59",DFNA59,11p14.2-q12.3,
OMIM:613364,"?Spastic paraplegia 41, autosomal dominant (2)",Spastic paraplegia 41,SPG41,11p14.1-p11.2,
OMIM:613636,"[Tuberculin skin test reactivity, absence of] (2)","Tuberculin skin test reactivity, absence of",TST1,11p14,
OMIM:194072,"Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (4)","Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (chromosome 11p13 deletion syndrome)","DEL11p13, C11DELp13, WAGR",11p13,
OMIM:117100,Centrotemporal epilepsy (2),Centrotemporal epilepsy,"ECT, BECTS",11p13,
OMIM:609256,Myopia 7 (2),Myopia 7,MYP7,11p13,
OMIM:609941,"Deafness, autosomal recessive 51 (2)","Deafness, autosomal recessive 51",DFNB51,11p13-p12,
OMIM:605750,Exudative vitreoretinopathy 3 (2),Exudative vitreoretinopathy 3,EVR3,11p13-p12,
OMIM:612469,WAGRO syndrome (4),"Wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome","WAGRO, DEL11p14p12",11p13-p12,
OMIM:607644,"Candidiasis, familial, 3 (2)","Candidiasis, familial, 3","CANDF3, CANDN1, FCNC",11p13-q12,
OMIM:614344,"Mental retardation, autosomal recessive 23 (2)","Mental retardation, autosomal recessive 23",MRT23,11p13-q14.1,
OMIM:611739,"{Osteoporosis}, 166710 (2)",Bone mineral density QTL 8,BMND8,11p12,
OMIM:610898,"Supranuclear palsy, progressive, 3 (2)","Supranuclear palsy, progressive, 3",PSNP3,11p12-p11,
OMIM:616229,"Osteogenesis imperfecta, type XVI (4)","Osteogenesis imperfecta, type XVI (chromosome 11p11.2 deletion syndrome, 91.3kb)","OI16, C16DELp11.2, DEL16p11.2",11p11.2,
OMIM:601224,Potocki-Shaffer syndrome (4),Potocki-Shaffer syndrome,PSS,11p11.2,
OMIM:609630,"{Leukemia, chronic lymphocytic, susceptibility to, 1} (2)","Leukemia, chronic lymphocytic, susceptibility to, 1",CLLS1,11p11,
OMIM:604499,"Hyperlipidemia, combined, 2 (2)","Hyperlipidemia, combined, 2",HYPLIP2,11p,
OMIM:600165,Nanophthalmos-1 (2),Nanophthalmos 1,NNO1,11p,
OMIM:608687,Spinocerebellar ataxia 20 (4),"Spinocerebellar ataxia 20 (chromosome 11q12 duplication syndrome, 260kb)","SCA20, DUP11q12, C11DUPq12",11q12,
OMIM:612795,[Polyunsaturated fatty acids plasma level QTL1] (2),Polyunsaturated fatty acids plasma level QTL1,PURAQTL1,11q12-q13.1,
OMIM:611958,"{Prostate cancer, hereditary, 14} (2)","Prostate cancer, hereditary, 14",HPC14,11q13,
OMIM:600319,"{Diabetes mellitus, insulin-dependent, 4} (2)",Insulin-dependent diabetes mellitus-4,IDDM4,11q13,
OMIM:166750,Otodental dysplasia chromsome deletion syndrome (4),Otodental dysplasia (chromosome 11q13 deletion syndrome),"OTDD, DEL11q13, C11DELq13",11q13,
OMIM:607088,"Spinal muscular atrophy, chronic distal, autosomal recessive (2)","Spinal muscular atrophy, chronic distal, autosomal recessive",SMAR,11q13,
OMIM:191181,Cervical carcinoma (2),"Suppression of tumorigenicity-3 (tumor-suppressor gene, HELA cell type)",ST3,11q13,
OMIM:613064,"{Dermatitis, atopic, susceptibility to, 7} (2)","Dermatitis, atopic, 7",ATOD7,11q13.5,
OMIM:607279,{Systemic lupus erythematosus with hemolytic anemia} (2),"Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1",SLEH1,11q14,
OMIM:603342,"{?Schizophrenia}, 181500 (2)","Schizophrenia susceptibility locus, chromosome 11-related",SCZD2,11q14-q21,
OMIM:612017,"Pyloric stenosis, infantile hypertrophic, 3 (2)","Pyloric stenosis, infantile hypertrophic, 3",IHPS3,11q14-q22,
OMIM:613233,[Fasting plasma glucose level QTL 3] (2),Fasting plasma glucose level QTL 3,FGQTL3,11q21-q22,
OMIM:609354,[Bone mineral density QTL 5] (2),Bone mineral density QTL 5,BMND5,11q23,
OMIM:600048,"Breast cancer, 11:22 translocation associated (1)","Breast cancer, 11;22 translocation associated",BRCATA,11q23,
OMIM:612232,"{Colorectal cancer, susceptibility to, 7} (2)","Colorectal cancer, susceptibility to, 7",CRCS7,11q23,
OMIM:137580,Tourette syndrome (2),Gilles de la Tourette syndrome,GTS,11q23,
OMIM:147791,Jacobsen syndrome (4),Jacobsen syndrome,JBS,11q23,
OMIM:613387,"{Fatty liver disease, nonalcoholic, susceptibility to, 2} (2)","Fatty liver disease, nonalcoholic, susceptibility to, 2",NAFLD2,11q23,
OMIM:188025,"?Thrombocytopenia, Paris-Trousseau type (4)","Thrombocytopenia, Paris-Trousseau type (deletion 11q23 syndrome)",TCPT,11q23,
OMIM:603040,{Nonsmall cell lung cancer} (2),Tumor suppressor gene on chromosome 11,TSG11,11q23,
OMIM:612629,"{Adiponectin, serum level of, QTL4} (2)","Adiponectin, serum level of, quantitative trait locus locus 4",ADIPQTL4,11q23-q24,
OMIM:605201,High density lipoprotein cholesterol level QTL14 (2),High density lipoprotein cholesterol level quantitative trait locus 14,"HDLCQ14, HYLAP",11q23.3,
OMIM:607086,"Aortic aneurysm, familial thoracic 1 (2)","Aortic aneurysm, familial thoracic 1","AAT1, FAA1",11q23.3-q24,
OMIM:609670,"{Migraine with aura, susceptibility to, 9} (2)","Migraine with aura, susceptibility to, 9",MGR9,11q24,
OMIM:609469,"Nephropathy, progressive, with deafness (2)","Nephropathy, progressive, with deafness",NEDE,11q24,
OMIM:612161,"Aneurysm, intracranial berry, 7 (2)","Aneurysm, intracranial berry, 7",ANIB7,11q24-q25,
OMIM:612559,"{Leukemia, chronic lymphocytic susceptibility to, 5} (2)","Leukemia, chronic lymphocytic susceptibility to, 5",CLLS5,11q24.1,
OMIM:602782,"Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)",Histiocytosis with joint contractures and sensorineural deafness,"HJCD, HCLAP",11q25,
OMIM:604060,"Deafness, autosomal recessive 20 (2)","Deafness, autosomal recessive 20",DFNB20,11q25-qter,
OMIM:606049,"Acromegaloid features, overgrowth, cleft palate, and hernia (2)","Acromegaloid features, overgrowth, cleft palate, and hernia",AOCH,Chr.11,
OMIM:612372,"{Major affective disorder-9, susceptibility to} (2)",Major affective disorder 9,MAFD9,12p13.3,
OMIM:610143,"Deafness, autosomal recessive 62 (2)","Deafness, autosomal recessive 62",DFNB62,12p13.2-p11.23,
OMIM:601458,{Inflammatory bowel disease 2} (2),Inflammatory bowel disease 2,IBD2,12p13.2-q24.1,
OMIM:130080,"Ehlers-Danlos syndrome, type VIII (2)","Ehlers-Danlos syndrome, type VIII",EDS8,12p13,
OMIM:608742,"{Hypertension, essential, susceptibility to, 4}, 145500 (2)","Hypertension, essential, susceptibility to, 4",HYT4,12p12.2-p12.1,
OMIM:602096,"Alzheimer disease-5, 104300 (2)","Alzheimer disease, familial, type 5",AD5,12p11.23-q13.12,
OMIM:615022,"Ichthyosis, congenital, autosomal recessive 7, 615022 (3)","Ichthyosis, congenital, autosomal recessive 7",ARCI7,12p11.2-q13.1,
OMIM:606257,{Stature QTL 3} (2),Stature quantitative trait locus 3,STQTL3,12p11.2-q14,
OMIM:615390,Vesicoureteral reflux 7 (2),Vesicoureteral reflux 7,VUR7,12p11-q13,
OMIM:601803,Pallister-Killian syndrome (4),Pallister-Killian syndrome,PKS,12p,
OMIM:179010,"Pyloric stenosis, infantile hypertrophic 1 (2)","Pyloric stenosis, infantile hypertrophic 1","IHPS1, IHPS",12q,
OMIM:608591,"Charcot-Marie-Tooth disease, axonal, type 2G (2)","Charcot-Marie-Tooth disease, axonal, type 2G",CMT2G,12q12-q13.3,
OMIM:102300,{Restless legs syndrome 1} (2),"Restless legs syndrome, susceptibility to, 1",RLS1,12q12-q21,
OMIM:613061,"{Basal cell carcinoma, susceptibility to, 4} (2)","Basal cell carcinoma, susceptibility to, 4",BCC4,12q13,
OMIM:616182,"{Chronic mountain sickness, susceptibility to} (2)","Chronic mountain sickness, susceptibility to",CMTS,12q13,
OMIM:184100,"Spondyloepiphyseal dysplasia tarda, autosomal dominant (2)","Spondyloepiphyseal dysplasia tarda, autosomal dominant",SPDT,12q13,
OMIM:607841,"Deafness, autosomal dominant 48 (2)","Deafness, autosomal dominant 48",DFNA48,12q13-q14,
OMIM:600808,"Enuresis, nocturnal, 2 (2)","Enuresis, nocturnal, 2",ENUR2,12q13-q21,
OMIM:614346,"Mental retardation, autosomal recessive 25 (2)","Mental retardation, autosomal recessive 25",MRT25,12q13.11-q15,
OMIM:614375,"Aortic aneurysm, familial abdominal, 4 (2)","Aortic aneurysm, familial abdominal, 4",AAA4,12q13.3,
OMIM:177700,"Glaucoma 1, open angle, P (4)","Glaucoma 1, open angle, P",GLC1P,12q14,
OMIM:610908,{Autism susceptibility 13} (2),"Autism, susceptibility to, 13",AUTS13,12q14.2,
OMIM:611547,{Stature QTL 9} (2),Stature quantitative trait locus 9,STQTL9,12q14.3,
OMIM:612639,{Inflammatory bowel disease 26} (2),Inflammatory bowel disease 26,IBD26,12q15,
OMIM:612715,Dyschromatosis universalis hereditaria 2 (2),Dyschromatosis universalis hereditaria 2,DUH2,12q21-q23,
OMIM:603221,Myopia-3 (2),"Myopia, high grade, 3, autosomal dominant",MYP3,12q21-q23,
OMIM:273300,Male germ cell tumor (2),Male germ cell tumor,MGCT,12q22,
OMIM:608520,"Major depressive disorder 1, 608516 (2)",Major depressive disorder,MDD1,12q22-q23.2,
OMIM:608096,"Epilepsy, familial temporal lobe, 2 (2)","Epilepsy, familial temporal lobe","ETL2, FTLE",12q22-q23.3,
OMIM:613096,"Spastic paraplegia 36, autosomal dominant (2)",Spastic paraplegia-36,SPG36,12q23-q24,
OMIM:612011,"{Celiac disease, susceptibility to, 13} (2)","Celiac disease, susceptibility to, 13",CELIAC13,12q24,
OMIM:608447,Carotid intimal medial thickness (2),Carotid intimal medial thickness,CIMT,12q24,
OMIM:607411,"{Patent ductus arteriosus, susceptibility to} (2)",Patent ductus arteriosus,PDA1,12q24,
OMIM:608437,"{Systemic lupus erythematosus, susceptibility to, 4} (2)","Systemic lupus erythematosus, susceptibility to, 4",SLEB4,12q24,
OMIM:609261,"Stuttering, familial persistent, 2 (2)","Stuttering, familial persistent, 2",STUT2,12q24.1,
OMIM:175850,"Porokeratosis 2, palmar, plantar, and disseminated (2)","Porokeratosis 2, palmar, plantar, and disseminated","POROK2, PPPD1",12q24.1-q24.2,
OMIM:601407,"Diabetes mellitus, noninsulin-dependent, 2 (2)","Diabetes mellitus, noninsulin-dependent, 2",NIDDM2,12q24.2,
OMIM:614422,"Cataract 37, autosomal dominant (2)",Cataract 37,"CTRCT37, CCA5",12q24.2-q24.3,
OMIM:612573,[Mean platelet volume QTL1] (2),Mean platelet volume quantitative trait locus 1,MPVQTL1,12q24.31,
OMIM:610158,"Corneal dystrophy, Fuchs endothelial, 2 (2)","Corneal dystrophy, Fuchs endothelial, 2","FECD2, FCD1",13pter-q12.13,
OMIM:604595,[Cholesterol level QTL 1] (2),Cholesterol level quantitative trait locus 1,"CLQTL1, CLF",13q,
OMIM:608557,"{Myocardial infarction, susceptibility to, 2} (2)","Myocardial infarction, susceptibility to, 2",MCI2,13q12,
OMIM:605844,"{Dermatitis, atopic, susceptibility to, 5} (2)","Dermatitis, atopic, 5",ATOD5,13q12-q14,
OMIM:612312,"{Attention deficit-hyperactivity disorder, susceptibility to, 6} (2)","Attention deficit-hyperactivity disorder, susceptibility to, 6",ADHD6,13q12.11,
OMIM:609384,"Fibrosis of extraocular muscles, congenital, 3C (2)","Fibrosis of extraocular muscles, congenital, 3C","CFEOM3C, FEOM4",13q12.11,
OMIM:614166,"Myopia 20, autosomal dominant (2)","Myopia 20, autosomal dominant",MYP20,13q12.12,
OMIM:157900,?Moebius syndrome (2),Moebius syndrome,"MBS, MBS1",13q12.2-q13,
OMIM:600631,"Enuresis, nocturnal, 1 (2)","Enuresis, nocturnal, 1",ENUR1,13q13-q14.3,
OMIM:612089,Hypophosphatemic rickets and hyperparathyroidism (2),Hypophosphatemic rickets and hyperparathyroidism,HPRHP,13q13.1,
OMIM:612796,{Inflammatory bowel disease 27} (2),Inflammatory bowel disease 27,IBD27,13q13.3,
OMIM:263450,"Polydactyly, postaxial, type A5 (2)","Polydactyly, postaxial, type A5",PAPA5,13q13.3-q21,
OMIM:606643,[Body mass index QTL2] (2),Body mass index quantitative trait locus 2,BMIQ2,13q14,
OMIM:612110,[Bone mineral density QTL 9] (2),Bone mineral density quantitative trait locus 9,BMND9,13q14,
OMIM:109543,"{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)","Leukemia, chronic lymphocytic, susceptibility to, 2","CLLS2, D13S25, DBM",13q14,
OMIM:613884,Chromosome 13q14 deletion syndrome (4),Chromosome 13q14 deletion syndrome,"DEL13q14, C13DELq14",13q14,
OMIM:109350,Gastroesophageal reflux (2),Gastroesophageal reflux,GER,13q14,
OMIM:601499,"Rieger syndrome, type 2 (2)","Rieger syndrome, type 2","RIEG2, RGS2",13q14,
OMIM:607584,"Spastic paraplegia 24, autosomal recessive (2)","Spastic paraplegia 24, autosomal recessive",SPG24,13q14,
OMIM:613407,"{Leprosy, susceptibility to, 6} (2)","Leprosy, susceptibility to, 6",LPRS6,13q14.11,
OMIM:608049,{Autism susceptibility 3} (2),"Autism, susceptibility to, 3",AUTS3,13q14.2-q14.1,
OMIM:612894,{Stature QTL 20} (2),Stature quantitative trait locus 20,STQTL20,13q14.3,
OMIM:605365,"?Breast cancer, type 3 (2)","Breast cancer, type 3","BRCA3, BRCAX",13q21,
OMIM:607134,"Specific language impairment QTL, 3 (2)","Specific language impairment QTL, 3",SLI3,13q21,
OMIM:602085,"Postaxial polydactyly, type A2 (2)","Postaxial polydactyly, type A2",PAPA2,13q21-q32,
OMIM:142700,Developmental dysplasia of the hip 1 (2),Developmental dysplasia of the hip 1,DDH1,13q22,
OMIM:167870,Panic disorder syndrome 1 (2),Panic disorder syndrome 1,PAND1,13q22-q32,
OMIM:193003,"Nystagmus 4, congenital, autosomal dominant (2)","Nystagmus 4, congenital, autosomal dominant",NYS4,13q31-q33,
OMIM:609572,Photoparoxysmal response 2 (2),Photoparoxysmal response 2,PPR2,13q31.3,
OMIM:610840,"Mitral valve prolapse, myxomatous 3 (2)","Mitral valve prolapse, myxomatous 3",MMVP3,13q31.3-q32.1,
OMIM:614629,Keratoconus 7 (2),Keratoconus 7,KTCN7,13q32,
OMIM:156600,"Microcoria, congenital (4)","Microcoria, congential (chromosome 13q32 deletion syndrome)","MCOR, C13DELq32, DEL13q32",13q32,
OMIM:603176,"{Schizophrenia}, 181500 (2)","Schizophrenia susceptibility locus, chromosome 13q-related",SCZD7,13q32,
OMIM:609903,"{Systemic lupus erythematosus, susceptibility to, 5} (2)","Systemic lupus erythematosus, susceptibility to, 5",SLEB5,13q32,
OMIM:606258,{Stature QTL 4} (2),Stature quantitative trait locus 4,STQTL4,13q32-q33,
OMIM:610361,Orofacial cleft 9 (2),Orofacial cleft 9,OFC9,13q33.1-q34,
OMIM:614318,Vesicoureteral reflux 5 (2),Vesicoureteral reflux 5,VUR5,13q33.2,
OMIM:614211,"Deafness, autosomal dominant 33 (2)","Deafness, autosomal dominant 33",DFNA33,13q34,
OMIM:606771,"{Adiponectin, serum level of, QTL3} (2)","Adiponectin, serum level of, quantitative trait locus 3","ADIPQTL3, CAQ14",14p11.2-q13,
OMIM:606675,{Inflammatory bowel disease 4} (2),Inflammatory bowel disease 4,IBD4,14q11-q12,
OMIM:613457,Chromosome 14q11-q22 deletion syndrome (4),Chromosome 14q11-q22 deletion syndrome,"DEL14q11q22, C14DELq11q22",14q11-q22,
OMIM:612851,{Narcolepsy 5} (2),Narcolepsy 5,NRCLP5,14q11.2,
OMIM:609965,"Deafness, autosomal dominant 53 (2)","Deafness, autosomal dominant 53",DFNA53,14q11.2-q12,
OMIM:611095,"Mental retardation, autosomal recessive, 9/26 (2)","Mental retardation, autosomal recessive, 9/26","MRT9, MRT26",14q11.2-q12,
OMIM:610420,"Preauricular tag, isolated, autosomal dominant, 1 (2)","Preauricular tag, isolated, autosomal dominant, 1",PAURT1,14q11.2-q12,
OMIM:144110,Hyperhidrosis palmaris et plantaris (2),Hyperhidrosis palmaris et plantaris,HHPP,14q11.2-q13,
OMIM:610234,Synpolydactyly 3 (2),Synpolydactyly 3,SPD3,14q11.2-q12,
OMIM:600792,"Deafness, autosomal recessive 5 (2)","Deafness, autosomal recessive 5",DFNB5,14q12,
OMIM:611252,"Spastic paraplegia 32, autosomal recessive (2)",Spastic paraplegia-32,SPG32,14q12-q21,
OMIM:602086,Arrhythmogenic right ventricular dysplasia 3 (2),Arrhythmogenic right ventricular dysplasia 3,ARVD3,14q12-q22,
OMIM:609408,Holoprosencephaly-8 (2),Holoprosencephaly 8,HPE8,14q13,
OMIM:608831,{Restless legs syndrome 2} (2),"Restless legs syndrome, susceptibility to, 2",RLS2,14q13-q21,
OMIM:607501,"{Migraine without aura, susceptibility to, 4} (2)","Migraine without aura, susceptibility to, 4","MGR4, MGOA",14q21.2-q22.3,
OMIM:115650,"Cataract 32, multiple types (2)","Cataract 32, multiple types","CTRCT32, CTAA1, CAP, CTPP5",14q22-q23,
OMIM:609640,Frias syndrome (4),Frias syndrome,"FRIASS, DEL14q22, C14DELq22",14q22.1-q22.3,
OMIM:255500,Myopia 18 (2),Myopia 18,MYP18,14q22.1-q24.2,
OMIM:612589,"{Colorectal cancer, susceptibility to, 8} (2)","Colorectal cancer, susceptibility to, 8",CRCS8,14q22.2,
OMIM:612162,"Aneurysm, intracranial berry, 8 (2)","Aneurysm, intracranial berry, 8",ANIB8,14q23,
OMIM:606972,"{Epilepsy, idiopathic generalized, susceptibility to, 2} (2)","Epilepsy, idiopathic generalized, susceptibility to, 2",EIG2,14q23,
OMIM:609113,"[Telomere length, mean leukocyte] (2)","Telomere length, mean leukocyte",TELM,14q23.2,
OMIM:613085,"Glaucoma 3, primary congenital, C (2)","Glaucoma 3, primary congenital, C",GLC3C,14q24.3,
OMIM:614628,Keratoconus 8 (2),Keratoconus 8,KTCN8,14q24.3,
OMIM:612083,Muscle strength quantitative trait locus 1 (2),Muscle strength quantitative trait locus 1,MUSTQTL1,14q24.3,
OMIM:601208,"{Diabetes mellitus, insulin-dependent, 11} (2)",Insulin-dependent diabetes mellitus-11,IDDM11,14q24.3-q31,
OMIM:275000,"{Graves disease, susceptibility to, 1} (2)","Graves disease, susceptibility to, 1",GRD1,14q31,
OMIM:614187,"Hypertelorism, preauricular sinus, punctal pits, and deafness (2)","Hypertelorism, preauricular sinus, punctal pits, and deafness",HPPD,14q31,
OMIM:608318,"{Coronary heart disease, susceptibility to, 4} (2)","Coronary heart disease, susceptibility to, 4",CHDS4,14q32,
OMIM:616604,"{Myeloproliferative neoplasms, familial, susceptibility to} (4)","Chromosome 14q32 duplication syndrome, 700kB","DUP14q32, C14DUPq32",14q32,
OMIM:608875,"{Gene expression, variation in, QTL} (2)","Gene expression, variation in, quantitative trait locus on chromosome 14",GEVQ1,14q32,
OMIM:164210,Hemifacial microsomia (2),Hemifacial microsomia,HFM,14q32,
OMIM:608149,Kagami-Ogata syndrome (4),Kagami-Ogata syndrome,KAOGS,14q32,
OMIM:251600,"Microphthalmia, isolated 1 (2)","Microphthalmia, isolated 1",MCOP1,14q32,
OMIM:616222,Temple syndrome (4),Temple syndrome (maternal uniparental disomy chromosome 14),TEMPS,14q32,
OMIM:614339,"Mental retardation, autosomal recessive 32 (2)","Mental retardation, autosomal recessive 32",MRT32,14q32.13-q32.2,
OMIM:608251,"Phobia, specific (2)","Phobia, specific",PHOBS,Chr.14,
OMIM:616606,Ring chromosome 14 syndrome (4),Ring chromosome 14 syndrome,RC14S,Chr.14,
OMIM:604329,"{Hypertension, essential, susceptibility to, 2}, 145500 (2)","Hypertension, essential, susceptibility to, 2",HYT2,15q,
OMIM:214900,Cholestasis-lymphedema syndrome (2),Cholestasis-lymphedema syndrome,"LCS1, CHLS",15q,
OMIM:608636,{Autism susceptibility 4} (2),"Autism, susceptibility to, 4",AUTS4,15q11,
OMIM:607202,"{Celiac disease, susceptibility to, 5} (2)","Celiac disease, susceptibility to, 5","CELIAC5, GSES",15q11-q13,
OMIM:609745,"Glaucoma 1, open angle, I (2)","Glaucoma 1, open angle, I",GLC1I,15q11-q13,
OMIM:122460,,Human coronavirus sensitivity,HCVS,15q11-qter,
OMIM:615656,Chromosome 15q11.2 deletion syndrome (4),Chromosome 15q11.2 deletion syndrome,"DEL15q11.2, C15DELq11.2",15q11.2,
OMIM:609179,"{Migraine with aura, susceptibility to, 7} (2)","Migraine with aura, susceptibility to, 7",MGR7,15q11.2-q12,
OMIM:610321,"{Prostate cancer, hereditary, 7} (2)","Prostate cancer, hereditary, 7",HPC7,15q12,
OMIM:605738,Microphthalmia with coloboma 2 (2),"Microphthalmia, isolated, with coloboma 2",MCOPCB2,15q12-q15,
OMIM:208500,Short-rib thoracic dysplasia 1 with or without polydactyly (2),Short-rib thoracic dysplasia 1 with or without polydactyly,"SRTD1, ATD1",15q13,
OMIM:613025,"{Schizophrenia, susceptibility to, 13} (2)",Schizophrenia 13,SCZD13,15q13,
OMIM:608646,"Ciliary dyskinesia, primary, 4 (2)","Ciliary dyskinesia, primary, 4",CILD4,15q13.1-q15.1,
OMIM:612001,Chromosome 15q13.3 microdeletion syndrome (4),Chromosome 15q13.3 microdeletion syndrome,"DEL15q13.3, MICRODEL15q13.3",15q13.3,
OMIM:604827,"{Epilepsy, idiopathic generalized, susceptibility to, 7} (2); Epilepsy, juvenile myoclonic (2)","Epilepsy, idiopathic generalized, susceptibility to, 7","EIG7, EJM2",15q14,
OMIM:616898,Chromosome 15q14 deletion syndrome (4),Chromosome 15q14 deletion syndrome,"DEL15q14, C15DELq14",15q14,
OMIM:605419,{Schizophrenia 10} (2),Schizophrenia 10,SCZD10,15q15,
OMIM:611102,Deafness and male infertility (4),Chromosome 15q15.3 deletion syndrome,"DEL15q15.3, C15DELq15.3",15q15.3,
OMIM:134600,Fanconi renotubular syndrome 1 (2),Fanconi renotubular syndrome,"FRTS1, FRTS, RFS",15q15.3,
OMIM:601228,"Polyposis syndrome, mixed hereditary 1 (4); {Colorectal cancer, susceptibility to, 4} (4)","Polyposis syndrome, mixed, hereditary 1","HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq",15q15.3-q22.1,
OMIM:105600,"Dyserythropoietic anemia, congenital, type III (2)","Congenital dyserythropoietic anemia, type III","CDAN3, CDA3",15q21,
OMIM:605728,Cataract 25 (2),Cataract 25,"CTRCT25, CCSSO",15q21-q22,
OMIM:612632,"Usher syndrome, type 1H (2)","Usher syndrome, type 1H",USH1H,15q22-q23,
OMIM:611274,"Glaucoma 1, open angle, N (2)","Glaucoma 1, open angle, N",GLC1N,15q22-q24,
OMIM:612579,{Stature QTL 16} (2),Stature quantitative trait locus 16,STQTL16,15q22.32,
OMIM:607248,{Glioma susceptibility 4} (2),Glioma susceptibility 4,GLM4,15q23-q26.3,
OMIM:613406,Chromosome 15q24 deletion syndrome (4),Chromosome 15q24 deletion syndrome,"DEL15q24, CHR15DELq24",15q24,
OMIM:603204,"Epilepsy, nocturnal frontal lobe, type 2 (2)","Epilepsy, nocturnal frontal lobe, type 2",ENFL2,15q24,
OMIM:602685,"Mental retardation, severe, with spasticity and tapetoretinal degeneration (2)","Mental retardation, severe, with spasticity and tapetoretinal degeneration",MRST,15q24,
OMIM:612274,"Ciliary dyskinesia, primary, 8 (2)","Ciliary dyskinesia, primary, 8",CILD8,15q24-q25,
OMIM:614294,Chromosome 15q25 deletion syndrome (4),Chromosome 15q25 deletion syndrome,"DEL15q25, C15DELq25",15q25,
OMIM:606451,"Deafness, autosomal dominant 30 (2)","Deafness, autosomal dominant 30",DFNA30,15q25-q26,
OMIM:607728,"Porokeratosis 4, disseminated superficial actinic (2)","Porokeratosis 4, disseminated superficial actinic","POROK4, DSAP2",15q25.1-q26.1,
OMIM:609893,"Hypothyroidism, congenital, nongoitrous, 3 (2)","Hypothyroidism, congenital, nongoitrous, 3","CHNG3, RTSH",15q25.3-q26.1,
OMIM:608691,"Major depressive disorder 2, 608516 (2)",Major depressive disorder 2,MDD2,15q25.3-q26.2,
OMIM:600318,"{Diabetes mellitus, insulin-dependent, 3} (2)",Insulin-dependent diabetes mellitus-3,IDDM3,15q26,
OMIM:609289,"Syncope, familial vasovagal (2)","Syncope, familial vasovagal",VVS,15q26,
OMIM:612626,Chromosome 15q26-qter deletion syndrome (4),Chromosome 15q26-qter deletion syndrome,"DEL15q26qter, C15DELq26qter",15q26-qter,
OMIM:614846,Levy-Shanske syndrome (4),Levy-Shanske syndrome (tetrasomy 15q26),LVSKS,15q26-qter,
OMIM:142340,"Hernia, congenital diaphragmatic 1 (2)","Hernia, congenital diaphragmatic 1","DIH1, HCD",15q26.1,
OMIM:166800,Otosclerosis 1 (2),Otosclerosis 1,"OTSC1, OTS",15q26.1-qter,
OMIM:141750,"Alpha-thalassemia/mental retardation syndrome, type 1 (4)","Alpha-thalassemia/mental retardation syndrome, type 1","HBHR, ATR1",16pter-p13.3,
OMIM:607339,"{Coronary heart disease, susceptibility to} (2)","Coronary heart disease, susceptibility to, 1",CHDS1,16pter-p13,
OMIM:613458,Chromosome 16p13.3 duplication syndrome (4),Chromosome 16p13.3 duplication syndrome,"DUP16p13.3, C16DUPq13.3",16p13.3,
OMIM:156850,Microphthalmia with cataract 1 (2),Microphthalmia with cataract 1,MCOPCT1,16p13.3,
OMIM:600273,"Polycystic kidney disease, infantile severe, with tuberous sclerosis (4)","Polycystic kidney disease, infantile severe, with tuberous sclerosis",PKDTS,16p13.3,
OMIM:610543,Chromosome 16p13.3 deletion syndrome (4),Chromosome 16p13.3 deletion syndrome (Rubinstein-Taybi deletion syndrome),"DEL16p13.3, RSTSS",16p13.3,
OMIM:616863,Chromosome 16p13.2 deletion syndrome (4),Chromosome 16p13.2 deletion syndrome,"DEL16p13.2, C16DELp13.2",16p13.2,
OMIM:608903,"{Attention deficit-hyperactivity disorder}, 143465 (2)","Attention deficit-hyperactivity disorder, susceptibility to, 1",ADHD1,16p13,
OMIM:608558,[Body mass index QTL5] (2),Body mass index quantitative trait locus 5,BMIQ5,16p13,
OMIM:610260,"Pyloric stenosis, infantile hypertrophic, 2 (2)","Pyloric stenosis, infantile hypertrophic, 2",IHPS2,16p13-p12,
OMIM:602594,Retinitis pigmentosa 22 (2),Retinitis pigmentosa-22,RP22,16p12.3-p12.1,
OMIM:613604,Chromosome 16p12.2-p11.2 deletion syndrome (4),Chromsome 16p12.2-p11.2 deletion syndrome,"DEL16p12.1p11.2, C16DELp12.1p11.2",16p12.2-p11.2,
OMIM:611096,"Mental retardation, autosomal recessive 10/20 (2)",611096,"MRT10, MRT20",16p12.2-q12.1,
OMIM:157700,"Mitral valve prolapse, myxomatous 1 (2)","Mitral valve prolapse, myxomatous 1","MMVP1, MVP, PMV",16p12.1-p11.2,
OMIM:136570,"Chromosome 16p12.1 deletion syndrome, 520kb (4)","Chromosome 16p12.1 deletion syndrome, 520kb","DEL16p12.1, C16DELp12.1",16p12,
OMIM:611247,Major affective disorder 4 (2),Major affective disorder 4,"MAFD4, BPAD",16p12,
OMIM:608105,"Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp (2)","Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp",EPRPDC,16p12-p11.2,
OMIM:613444,"Chromosome 16p11.2 deletion syndrome, 220kb (4); [Body mass index QTL16] (4)","Chromosome 16p11.2 deletion syndrome, 220kb","BMIQ16, DEL16p.11.2, C16DELp11.2",16p11.2,
OMIM:611913,"Chromosome 16p11.2 deletion syndrome, 593kb (4); {Autism susceptibility 14A} (2)","Chromosome 16p11.2 deletion syndrome, 593kb","DEL16p11.2, C16DELp11.2, AUTS14A",16p11.2,
OMIM:614671,"Chromosome 16p11.2 duplication syndrome (4); {Autism, susceptibility to, 14B} (2)",Chromosome 16p11.2 duplication syndrome,"DUP16p11.2, C16DUPp11.2, AUTS14B",16p11.2,
OMIM:615835,,Chromosome 16p11 inversion (0.45Mb),INV16p11,16p11,
OMIM:606668,{Inflammatory bowel disease 8} (2),Inflammatory bowel disease 8,IBD8,16p,
OMIM:610707,{Psoriasis susceptibility 8} (2),Psoriasis susceptibility 8,PSORS8,16q,
OMIM:606711,"Specific language impairment QTL, 1 (2)","Specific language impairment QTL, 1",SLI1,16q,
OMIM:194090,"Wilms tumor, type 3 (2)",Wilms tumor-3,WT3,16q,
OMIM:610753,Alopecia areata 2 (2),Alopecia areata 2,AA2,16q11-q22,
OMIM:126900,Dupuytren contracture 1 (2),Dupuytren contracture 1,DUPC1,16q11.1-q22,
OMIM:602639,"Tooth agenesis, selective, 2 (2)","Tooth agenesis, selective, 2","STHAG2, HYD2",16q12.1,
OMIM:614668,"Stuttering, familial persistent, 4 (2)","Stuttering, familial persistent, 4",STUT4,16q12.1-q23.1,
OMIM:605746,Anisomastia (2),Anisomastia,ANMA,16q13-q21,
OMIM:611031,Episodic kinesigenic dyskinesia 2 (2),Episodic kinesigenic dyskinesia 2,EKD2,16q13-q22.1,
OMIM:616648,Optic atroph 8 (2),Optic atrophy 8,OPA8,16q21-q22,
OMIM:613055,"Atrial fibrillation, familial, 8 (2)","Atrial fibrillation, familial, 8",ATFB8,16q22,
OMIM:614541,Chromosome 16q22 deletion syndrome (4),Chromosome 16q22 deletion syndrome,"C16DELq22, DEL16q22",16q22,
OMIM:612590,"{Colorectal cancer, susceptibility to, 9} (2)","Colorectal cancer, susceptibility to, 9",CRCS9,16q22.1,
OMIM:600223,Spinocerebellar ataxia 4 (2),Spinocerebellar ataxia 4,SCA4,16q22.1,
OMIM:611571,{Otosclerosis 4} (2),Otosclerosis 4,OTSC4,16q22.1-q23.1,
OMIM:608932,Keratoconus 2 (2),Keratoconus 2,KTCN2,16q22.3-q23.1,
OMIM:612727,[Bone mineral density QTL 13] (2),Bone mineral density quantitative trait locus 13,BMND13,16q23,
OMIM:608462,"{Hirschsprung disease, susceptibility to, 8} (2)","Hirschsprung disease, susceptibility to, 8",HSCR8,16q23,
OMIM:613836,"{Adiponectin, serum level of, QTL5] (2)","Adiponectin, serum level of, quantitative trait locus 5",ADIPQTL5,16q23.3,
OMIM:613547,{Stature QTL 22} (2),Stature quantitative trait locus 22,STQTL22,16q24,
OMIM:607687,"{High density lipoprotein cholesterol, low serum, 3} (2)","High density lipoprotein cholesterol, low serum, 3",HDLC3,16q24.1,
OMIM:612525,"Pyloric stenosis, infantile hypertrophic, 5 (2)","Pyloric stenosis, infantile hypertrophic, 5",IHPS5,16q24.3,
OMIM:125260,,Vesicular stomatitis virus defective interfering particle repressor,"VDI, DIPI",Chr.16,
OMIM:247200,Miller-Dieker lissencephaly syndrome (4),Miller-Dieker lissencephaly syndrome (chromosome 17p13.3 deletion syndrome),"MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3",17p13.3,
OMIM:613215,Chromosome 17p13.3 duplication syndrome (4),Chromosome 17p13.3 duplication syndrome,"DUP17p13.3, C17DUPp13.3",17p13.3,
OMIM:612576,Split-hand/foot malformation with long bone deficiency 3 (4),Split-hand/foot malformation with long bone deficiency 3,"SHFLD3, DUP17p13.3, C17DUPp13.3",17p13.3-p13.1,
OMIM:614341,"Mental retardation, autosomal recessive 33 (2)","Mental retardation, autosomal recessive 33",MRT33,17p13.2-p13.1,
OMIM:613776,Chromosome 17p13.1 deletion syndrome (4),Chromosome 17p13.1 deletion syndrome,"DEL17p13.1, C17DELp13.1",17p13.1,
OMIM:608631,{Asperger syndrome susceptibility 2} (2),"Asperger syndrome, susceptibility to, 2",ASPG2,17p13,
OMIM:601202,"Cataract 24, anterior polar (2)","Cataract 24, anterior polar","CTRCT24, CTAA2",17p13,
OMIM:605779,"Nail disorder, nonsyndromic congenital, 7 (2)","Nail disorder, nonsyndromic congenital, 7 (onychodysplasia, isolated congenital)",NDNC7,17p13,
OMIM:613498,[Sex hormone-binding globulin circulating level QTL 1] (2),Sex hormone-binding globulin circulating level quantitative trait locus 1,SXGQTL1,17p13,
OMIM:605572,Abdominal obesity-metabolic syndrome (2),Abdominal obesity-metabolic syndrome QTL2,AOMS2,17p12,
OMIM:616652,Yuan-Harel-Lupski syndrome (4),Yuan-Harel-Lupski syndrome,YUHAL,17p12-p11.2,
OMIM:613392,"Deafness, autosomal recessive 85 (2)","Deafness, autosomal recessive 85",DFNB85,17p12-q11.2,
OMIM:614928,"Ectodermal dysplasia 6, hair/nail type (2)","Ectodermal dysplasia 6, hair/nail type",ECTD6,17p12-q21.2,
OMIM:607354,"Scoliosis, idiopathic 2 (2)","Scoliosis, idiopathic 2","IS2, AIS2",17p11.2,
OMIM:610883,Potocki-Lupski syndrome (4),Potocki-Lupski syndrome,PTLS,17p11.2,
OMIM:604547,,Van der Woude syndrome modifier,VWSM,17p11.2-p11.2,
OMIM:608904,"{Attention deficit-hyperactivity disorder}, 143465 (2)","Attention deficit-hyperactivity disorder, susceptibility to, 2",ADHD2,17p11,
OMIM:215500,"Choroidal dystrophy, central areolar 1 (2)","Choroidal dystrophy, central areolar 1",CACD1,17p,
OMIM:603918,"{Hypertension, essential, susceptibility to, 1}, 145500 (2)","Hypertension, essential, susceptibility to, 1",HYT1,17q,
OMIM:609378,{Autism susceptibility 6} (2),"Autism, susceptibility to, 6",AUTS6,17q11,
OMIM:613675,"Chromosome 17q11.2 deletion syndrome, 1.4Mb (4)","Chromosome 17q11.2 deletion syndrome, 1.4Mb (NF1 microdeletion syndrome)","DEL17q11.2, C17DELq11.2",17q11.2,
OMIM:612575,[Mean platelet volume QTL3] (2),Mean platelet volume quantitative trait locus 3,MPVQTL3,17q11.2,
OMIM:154275,{Malignant hyperthermia susceptibility 2} (2),Malignant hyperthermia susceptibility 2,MHS2,17q11.2-q24,
OMIM:614527,Chromosome 17q12 deletion syndrome (4),Chromosome 17q12 deletion syndrome,"DEL17q12, C17DELq12",17q12,
OMIM:614526,Chromosome 17q12 duplication syndrome (4),Chromosome 17q12 duplication syndrome,"DUP17q12, C17DUPq12",17q12,
OMIM:611955,"{Prostate cancer, hereditary, 11} (2)","Prostate cancer, hereditary, 11",HPC11,17q12,
OMIM:614221,"Biliary cirrhosis, primary, 5 (2)","Biliary cirrhosis, primary, 5",PBC5,17q12,
OMIM:601363,"Wilms tumor, type 4 (2)",Wilms tumor-4,WT4,17q12-q21,
OMIM:611403,"{Asthma-related traits, susceptibility to, 6} (2)","Asthma-related traits, susceptibility to, 6",ASRT6,17q21,
OMIM:610676,{Autism susceptibility 7} (2),"Autism, susceptibility to, 7",AUTS7,17q21,
OMIM:610997,"{Prostate cancer, hereditary, 9} (2)","Prostate cancer, hereditary, 9",HPC9,17q21-q22,
OMIM:608474,Myopia 5 (2),Myopia 5,MYP5,17q21-q22,
OMIM:168860,Patella aplasia or hypoplasia (2),Patella aplasia or hypoplasia,"PTLAH, FPAH",17q21-q22,
OMIM:612380,{Inflammatory bowel disease 22} (2),Inflammatory bowel disease 22,IBD22,17q21.2,
OMIM:615674,Dowling-Degos disease 3 (2),Dowling-Degos disease 3,DDD3,17q21.3-q22,
OMIM:613533,Chromosome 17q21.31 duplication syndrome (4),Chromosome 17q21.31 duplication syndrome,"DUP17q21.31, C17DUPq21.31",17q21.31,
OMIM:615162,"Mental retardation, autosomal recessive 35, 615162 (3)","Mental retardation, autosomal recessive 35",MRT35,17q21.31-q22,
OMIM:609656,{Bone size QTL} (2),Bone size quantitative trait locus 1,BSZQTL,17q23,
OMIM:613355,Chromosome 17q23.1-q23.2 deletion syndrome (4),Chromosome 17q23.1-q23.2 deletion syndrome,"DEL17q23.1q23.2, C17DELq23.1q23.2",17q23.1-q23.2,
OMIM:613618,Chromosome 17q23.1-q23.2 duplication syndrome (4),Chromosome 17q23.1-q23.2 duplication syndrome,"DUP17q23.1q23.2, C17DUPq23.1q23.2",17q23.1-q23.2,
OMIM:612967,[Body mass index QTL 15] (2),Body mass index quantitative trait locus 15,BMIQ15,17q23.2-q25.1,
OMIM:115660,Cataract 7 (2),Cataract 7,"CTRCT7, CCA1",17q24,
OMIM:616425,46XY sex reversal 10 (4),"46,XY sex reversal 10",SRXY10,17q24,
OMIM:135400,"Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (4)","Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (chromosome 17q24 microdeletion syndrome)","HTGH, DEL17q24",17q24.2-q24.3,
OMIM:278850,46XX sex reversal 2 (4),46XX sex reversal 2,"SRXX2, DUP17q24.3",17q24.3-q25.1,
OMIM:261800,Pierre Robin syndrome (2),Pierre Robin syndrome,PRBNS,17q24.3-q25.1,
OMIM:614163,"{Delayed sleep phase syndrome, susceptibility to} (2)","Delayed sleep phase syndrome, susceptibliity to",DSPS,17q25,
OMIM:614149,"Nail disorder, nonsyndromic congenital, 9 (2)","Nail disorder, nonsyndromic congenital, 9 (anonychia-onycholysis)",NDNC9,17q25.1-q25.3,
OMIM:605805,"{Dermatitis, atopic, susceptibility to, 4} (2)","Dermatitis, atopic, 4",ATOD4,17q25.3,
OMIM:612239,"{Scoliosis, idiopathic, susceptibility to, 5} (2)","Scoliosis, idiopathic, susceptibility to, 5",IS5,17q25.3,
OMIM:610064,"{Opioid dependence, susceptibility to, 1} (2)","Opioid dependence, susceptibility to, 1",ODS1,Chr.17,
OMIM:609647,"Deafness, autosomal recessive 46 (2)","Deafness, neurosensory, autosomal recessive 46",DFNB46,18p11.32-p11.31,
OMIM:160700,Myopia-2 (2),"Myopia, high grade, autosomal dominant 1",MYP2,18p11.31,
OMIM:612353,"Porokeratosis 6, multiple types (2)",Porokeratosis 6,"POROK6, DSAP4",18p11.3,
OMIM:614343,"Mental retardation, autosomal recessive 19 (2)","Mental retardation, autosomal recessive 19",MRT19,18p11.3,
OMIM:104000,Alopecia areata 1 (2),Alopecia areata 1,AA1,18p11.3-p11.2,
OMIM:612410,{Psoriasis susceptibility 10} (2),Psoriasis susceptibility 10,PSORS10,18p11.23,
OMIM:107200,"Anosmia, isolated congenital (2)","Anosmia, isolated congenital",ANIC,18p11.23-q12.2,
OMIM:606616,"{Dyslexia, susceptibility to, 6} (2)","Dyslexia, susceptibility to, 6","DYX6, DYXQTL18",18p11.2,
OMIM:609253,"Febrile seizures, familial, 6 (2)","Febrile seizures, familial, 6",Feb6,18p11.2,
OMIM:607488,"Dystonia-15, myoclonic (2)","Dystonia-15, myoclonic",DYT15,18p11,
OMIM:612354,{Inflammatory bowel disease 21} (2),Inflammatory bowel disease 21,IBD21,18p11,
OMIM:146390,Chromosome 18p deletion syndrome (4),Chromosome 18p deletion syndrome,"DEL18p, C18DELp",18p,
OMIM:602124,"Dystonia-7, torsion (2)","Dystonia-7 (torsion dystonia, adult-onset, focal)",DYT7,18p,
OMIM:125480,{Major affective disorder 1} (2),Major affective disorder 1,"MAFD1, BPAD, MD1",18p,
OMIM:603206,"{Schizophrenia}, 181500 (2)","Schizophrenia susceptibility locus, chromosome 18-related",SCZD8,18p,
OMIM:614290,Tetrasomy 18p (4),Tetrasomy 18p,TET18P,18p,
OMIM:601808,Chromosome 18q deletion syndrome (4),Chromosome 18q deletion syndrome,DEL18q,18q,
OMIM:143850,Orthostatic hypotensive disorder of Streeten (2),Orthostatic hypotensive disorder of Streeten,OHDS,18q,
OMIM:613930,Alopecia-mental retardation syndrome 3 (2),Alopecia-mental retardation syndrome 3,APMR3,18q11.2-q12.2,
OMIM:605293,Optic atrophy 4 (2),Optic atrophy 4,OPA4,18q12.2-q12.3,
OMIM:614319,Vesicoureteral reflux 6 (2),Vesicoureteral reflux 6,VUR6,18q12.3,
OMIM:606640,Amyotrophic lateral sclerosis 3 (2),Amyotrophic lateral sclerosis 3,ALS3,18q21,
OMIM:601941,"{Diabetes mellitus, insulin-dependent, 6} (2)",Insulin-dependent diabetes mellitus-6,IDDM6,18q21,
OMIM:600624,Cone-rod retinal dystrophy-1 (2),"Cone rod dystrophy 1, autosomal dominant","CORD1, CRD1",18q21.1-q21.3,
OMIM:611014,"{Hypertension, essential, susceptibility to, 8} (2)","Hypertension, essential, susceptibility to, 8",HYT8,18q21.2,
OMIM:212200,Carnosinemia (2),Carnosinemia (carnosinase),CNSN,18q21.3,
OMIM:609334,Chromosome 18 pericentric inversion (4),Chromosome 18 pericentric inversion,"DUP18pDEL18q, DUP18qDEL18p",18q22,
OMIM:602401,"Ectodermal dysplasia 8, hair/tooth/nail type (2)","Ectodermal dysplasia 8, hair/tooth/nail type",ECTD8,18q22.1-q22.3,
OMIM:614233,"Hyperpigmentation, familial progressive, 1 (2)","Hyperpigmentation, familial progressive, 1","FPH1, MUH, HPP",19pter-p13.1,
OMIM:120050,,Coxsackie virus B3 sensitivity,CXB3S,19pter-q13,
OMIM:181800,"Scoliosis, idiopathic 1 (2)",Adolescent idiopathic scoliosis,"IS1, AIS",19p13.3,
OMIM:602477,"Febrile seizures, familial, 2 (2)","Febrile seizures, familial, 2",Feb2,19p13.3,
OMIM:601846,Muscular dystrophy with rimmed vacuoles (2),Muscular dystrophy with rimmed vacuoles,MDRV,19p13.3,
OMIM:108725,"{Atherosclerosis, susceptibility to} (2)",Atherosclerosis susceptibility (lipoprotein associated),"ATHS, ALP",19p13.3-p13.2,
OMIM:608907,"{Alzheimer disease 9, late onset, susceptibility to}, 104300 (2)",Alzheimer disease 9,AD9,19p13.2,
OMIM:614223,Narcolepsy 6 (2),Narcolepsy 6,NRCLP6,19p13.2,
OMIM:184700,Polycystic ovary syndrome 1 (2),Polycystic ovary syndrome 1,"PCOS1, PCO1, PCO",19p13.2,
OMIM:603386,"Thyroid carcinoma, nonmedullary, with cell oxyphilia (2)","Thyroid carcinoma, nonmedullary, with cell oxyphilia",TCO,19p13.2,
OMIM:607324,"Polydactyly, postaxial, type A3 (2)","Polydactyly, postaxial, type A3",PAPA3,19p13.2-p13.1,
OMIM:613638,Chromosome 19p13.13 deletion syndrome (4); Chromosome 19p13.13 duplication syndrome (4),Chromosome 19p13.13 deletion syndrome (Chromosome 19p13.13 duplication syndrome),"DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13",19p13.13,
OMIM:606674,{Inflammatory bowel disease 6} (2),Inflammatory bowel disease 6,IBD6,19p13,
OMIM:607508,"{Migraine with or without aura, susceptibility to, 5} (2)","Migraine with or without aura, susceptibility to, 5",MGR5,19p13,
OMIM:615830,"Pigmented nodular adrenocortical disease, primary, 4 (4)","Pigmented nodular adrenocortical disease, primary, 4",PPNAD4,19p13,
OMIM:605364,{Psoriasis susceptibility 6} (2),Psoriasis susceptibility 6,PSORS6,19p13,
OMIM:600209,"Exostoses, multiple, type 3 (2)","Exostoses, multiple, 3",EXT3,19p,
OMIM:601764,"Seizures, benign familial infantile, 1 (2)",Benign familial infantile seizures,"BFIS1, BFIC1",19q,
OMIM:607592,"{Prostate cancer aggressiveness QTL}, 176807 (2)",Prostate cancer aggressiveness quantitative trait locus on chromosome 19,HPCQTL19,19q,
OMIM:606712,"Specific language impairment QTL, 2 (2)","Specific language impairment QTL, 2",SLI2,19q,
OMIM:606875,"{Hirschsprung disease, susceptibility to, 7} (2)","Hirschsprung disease, susceptibility to, 7",HSCR7,19q12,
OMIM:100070,"Aortic aneurysm, familial abdominal 1 (2)","Aortic aneurysm, familial abdominal 1","AAA1, AAA",19q13,
OMIM:608542,"Aneurysm, intracranial berry, 2 (2)","Aneurysm, intracranial berry, 2",ANIB2,19q13,
OMIM:609376,"Cataract 35, congenital nuclear (2)",Cataract 35,"CTRCT35, CATCN1",19q13,
OMIM:611907,"Episodic ataxia, type 7 (2)","Episodic ataxia, type 7",EA7,19q13,
OMIM:600757,Orofacial cleft-3 (2),Orofacial cleft-3,OFC3,19q13,7(Cebpa)
OMIM:614746,"[Uric acid concentration, serum, QTL5] (2)","Uric acid concentration, serum, quantitative trait locus 5",UAQTL5,19q13,
OMIM:613026,Chromosome 19q13.11 deletion syndrome (4),Chromosome 19q13.11 deletion syndrome,"DEL19q13.11, C19DELq13.11",19q13.11,
OMIM:129150,,Echo 11 sensitivity,E11S,19q13.1-qter,
OMIM:227050,Transient erythroblastopenia of childhood (2),Transient erythroblastopenia of childhood,TEC,19q13.2,
OMIM:611097,"Mental retardation, autosomal recessive, 11 (2)","Mental retardation, autosomal recessive, 11",MRT11,19q13.2-q13.3,
OMIM:603855,"{Meconium ileus in cystic fibrosis, susceptibility to} (2)",Cystic fibrosis modifier-1,CFM1,19q13.2-q13.4,7(Cfm1)
OMIM:611959,"{Prostate cancer, hereditary, 15} (2)","Prostate cancer, hereditary, 15",HPC15,19q13.4,
OMIM:612884,"{Menopause, natural, age at, QTL2} (2)","Menopause, natural, age at, QTL2",MENOQ2,19q13.4,
OMIM:608559,[Body mass index QTL6] (2),Body mass index quantitative trait locus 6,BMIQ6,20pter-p11.2,
OMIM:608031,Amyotrophic lateral sclerosis 7 (2),Amyotrophic lateral sclerosis 7,ALS7,20p13,
OMIM:611242,{Restless legs syndrome 5} (2),"Restless legs syndrome, susceptibility to, 5",RLS5,20p13,
OMIM:611738,"{Osteoporosis}, 166710 (2)",Bone mineral density QTL 7,BMND7,20p12.3,
OMIM:612592,"{Colorectal cancer, susceptibility to, 11} (2)","Colorectal cancer, susceptibility to, 11",CRCS11,20p12.3,
OMIM:608696,"Glaucoma 1K, primary open angle, juvenile-onset (2)","Glaucoma 1K, primary open angle, juvenile-onset","GLC1K, JOAG3",20p12,
OMIM:610065,"{Systemic lupus erythematosus, susceptibility to, 7} (2)","Systemic lupus erythematosus, susceptibility to, 7",SLEB7,20p12,
OMIM:612421,"Alopecia, androgenetic, 3 (2)","Alopecia, androgenetic, 3",AGA3,20p11.22,
OMIM:612406,"Dystonia-17, primary torsion (2)","Dystonia-17, primary torsion",DYT17,20p11.2-q13.12,
OMIM:607116,"Alzheimer disease 8, 104300 (2)",Alzheimer disease 8,AD8,20p,
OMIM:605804,"{Dermatitis, atopic, susceptibility to, 3} (2)","Dermatitis, atopic, 3",ATOD3,20p,
OMIM:610261,"{Hypertension, essential, susceptibility to, 5}, 145500 (2)","Hypertension, essential, susceptibility to, 5",HYT5,20q11-q13,
OMIM:608029,"Spinocerebellar ataxia, autosomal recessive 6 (2)","Spinocerebellar ataxia, autosomal recessive 6","SCAR6, CLA3",20q11-q13,
OMIM:612263,"{Melanoma, cutaneous malignant, 7} (2)","Melanoma, cutaneous malignant, susceptibility to, 7",CMM7,20q11.2,
OMIM:601308,,Myeloid leukemia-related locus (myeloid tumor suppressor),"MLRL, MTS",20q11.2-q12,
OMIM:612228,{Stature QTL 14} (2),Stature quantitative trait locus 14,STQTL14,20q11.22,
OMIM:603694,"{Diabetes mellitus, noninsulin-dependent}, 125853 (2)",Noninsulin-dependent diabetes mellitus 3,NIDDM3,20q12-q13.1,
OMIM:613938,"Parasomnia, sleepwalking type (2)","Parasomnia, sleepwalking type",PSMNSW,20q12-q13.12,
OMIM:608878,"{Gene expression, variation in, QTL} (2)","Gene expression, variation in, quantitative trait locus on chromosome 20",GEVQ2,20q13,
OMIM:608656,"{Prostate cancer, susceptibility to, 3}, 176807 (2)","Prostate cancer, hereditary, 3",HPC3,20q13,
OMIM:612566,{Inflammatory bowel disease 24} (2),Inflammatory bowel disease 24,IBD24,20q13,
OMIM:612950,{Psoriasis susceptibility 12} (2),Psoriasis susceptibility 12,PSORS12,20q13,
OMIM:610066,"{Systemic lupus erythematosus, susceptibility to, 8} (2)","Systemic lupus erythematosus, susceptibility to, 8",SLEB8,20q13,
OMIM:603388,"{Graves disease, susceptibility to, 2} (2)","Graves disease, susceptibility to, 2",GRD2,20q13.11,
OMIM:610248,"Deafness, autosomal recessive 65 (2)","Deafness, autosomal recessive 65",DFNB65,20q13.2-q13.3,
OMIM:130180,,Electro-encephalographic variant pattern-1,"EEGV1, EEGL",20q13.2-q13.3,
OMIM:612929,"{Mycobacterium tuberculosis, susceptibility to, 3} (2)","Mycobacterium tuberculosis, susceptibility to, 3",MTBS3,20q13.31-q13.33,
OMIM:613031,{Glioma susceptibility 6} (2),Glioma susceptibility 6,GLM6,20q13.33,
OMIM:610838,{Autism susceptibility 12} (2),"Autism, susceptibility to, 12",AUTS12,21p13-q11,
OMIM:609039,Narcolepsy 3 (2),Narcolepsy 3,NRCLP3,21q11.2,
OMIM:159595,"Leukemia, transient, of Down syndrome (2)","Myeloproliferative syndrome, transient (transient abnormal myelopoiesis)","TAM, MST",21q11.2,
OMIM:602097,"Usher syndrome, type 1E (2)","Usher syndrome-1E, autosomal recessive, severe",USH1E,21q21,
OMIM:611515,"Febrile seizures, familial, 7 (2)","Febrile seizures, familial, 7",Feb7,21q22,
OMIM:609428,Tukel syndrome (2),Tukel syndrome,TUKLS,21q22,
OMIM:609633,"{Major affective disorder 3, early onset} (2)",Major affective disorder 3,"MAFD3, BPEO",21q22.13,
OMIM:609876,[Bone mineral density QTL 6] (2),Bone mineral density QTL 6,BMND6,21q22.13-qter,
OMIM:190685,Down syndrome (4),Down syndrome chromosome region,"DCR, DSCR",21q22.3,
OMIM:236100,Holoprosencephaly-1 (2),"Holoprosencephaly-1, alobar",HPE1,21q22.3,
OMIM:125520,Cayler cardiofacial syndrome (2),Asymmetric crying facies (Cayler cardiofacial syndrome),ACF,22q11,
OMIM:115470,Cat eye syndrome (4),Cat eye syndrome,"CECR, CES",22q11,
OMIM:611867,"Chromosome 22q11.2 deletion syndrome, distal (4)","Chromosome 22q11.2 deletion syndrome, distal","DEL22q11.2, C22DELq11.2",22q11.2,
OMIM:608363,Chromosome 22q11.2 microduplication syndrome (4),Chromosome 22q11.2 microduplication syndrome,DUP22q11.2,22q11.2,
OMIM:613700,Supernumerary der(22)t(8-22) syndrome (4),Supernumerary der(22)t(8;22) syndrome,DER22t8-22,22q11.2,
OMIM:609029,Emanuel syndrome (4),Emanuel syndrome (supernumerary der(22)t(11;22) syndrome),DER22t11-22,22q11.2,
OMIM:608264,"Deafness, autosomal recessive 40 (2)","Deafness, autosomal recessive 40",DFNB40,22q11.21-q12.1,
OMIM:613106,"Vertigo, benign recurrent, 2 (2)","Vertigo, benign recurrent, 2",BRV2,22q12,
OMIM:608207,"{Kala-azar, susceptibility to, 1} (2)","Kala-azar (visceral leishmaniasis), susceptibility to, 1",KAZA1,22q12,
OMIM:611004,{Smoking as a quantitative trait locus 2} (2),Smoking as a quantitative trait locus 2,SQTL2,22q12,
OMIM:603116,CDAGS syndrome (2),"Craniosynostosis, anal anomalies, and porokeratosis syndrome",CDAGS,22q12-q13,
OMIM:613284,[Hematocrit/hemoglobin quantitative trait locus 3] (2),Hematocrit/hemoglobin quantitative trait locus 3,HCHGQ3,22q12-q13,
OMIM:606960,Insulinoma (1),Insulinoma tumor suppressor gene locus,ITS,22q12.1-q12.2,
OMIM:610708,Optic atrophy 5 (2),Optic atrophy 5,OPA5,22q12.1-q13.1,
OMIM:609558,"{Prostate cancer, susceptibility to}, 176807 (2)","Prostate cancer, hereditary, 6",HPC6,22q12.3,
OMIM:613689,Mammary-digital-nail syndrome (2),Mammary-digital-nail syndrome,MDNS,22q12.3-q13.1,
OMIM:615538,"Chromosome 22q13 duplication syndrome, 615538 (4)",Chromosome 22q13 duplication syndrome,"DUP22q13, C22DUPq13",22q13,
OMIM:610873,"{Menarche, age at, QTL} (2)","Menarche, age at, QTL 1",MENAQ1,22q13,
OMIM:613282,"{Fatty liver disease, nonalcoholic, susceptibility to, 1} (2)","Fatty liver disease, nonalcoholic, susceptibility to, 1",NAFLD1,22q13,
OMIM:612417,{Narcolepsy 4} (2),Narcolepsy 4,NRCLP4,22q13,
OMIM:300221,"{Hodgkin disease susceptibility, pseudoautosomal} (2)","Hodgkin disease, susceptibility, pseudoautosomal",HDPA,Xpter-p22.32,
OMIM:313000,Turner syndrome-associated neurocognitive phenotype (2); [Visuospatial/perceptual abilities] (2),Visuospatial/perceptual abilities,VSPA,Xp22.33,
OMIM:314705,,XG/MIC2 regulator,XGR,Xp22.32,
OMIM:300211,"Episodic muscle weakness, X-linked (2)","Episodic muscle weakness, X-linked",EMWX,Xp22.3,
OMIM:300778,"Corneal dystrophy, Lisch epithelial (2)","Corneal dystrophy, Lisch epithelial",LECD,Xp22.3,
OMIM:300428,"Mental retardation, X-linked 2 (2)","Mental retardation, X-linked, 2",MRX2,Xp22.3,
OMIM:300114,"Mental retardation, X-linked 49 (2)","Mental retardation, X-linked-49",MRX49,Xp22.3,
OMIM:302801,"Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 (2)","Charcot-Marie-Tooth disease, X-linked recessive, 2",CMTX2,Xp22.2,
OMIM:305435,Fetal hemoglobin quantitative trait locus 3 (2),Fetal hemoglobin quantitative trait locus 3,"HBFQTL3, FCP1, FCPX, FCP",Xp22.2,
OMIM:300355,"Mental retardation, X-linked 73 (2)","Mental retardation, X-linked 73",MRX73,Xp22.2,
OMIM:300148,MEHMO syndrome (2),"MEHMO syndrome (Mental retardation, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, and obesity)",MEHMO,Xp22.13-p21.1,
OMIM:300310,"Agammaglobulinemia, X-linked 2 (2)","Agammaglobulinemia, X-linked 2 (with growth hormone deficiency)","AGMX2, XLA2, IMD6",Xp22,X(Xid)
OMIM:304050,Aicardi syndrome (2),Aicardi syndrome,AIC,Xp22,
OMIM:300870,"Aneurysm, intracranial berry, 5 (2)","Aneurysm, intracranial berry, 5",ANIB5,Xp22,
OMIM:300273,"Goiter, multinodular, 2 (2)",Multinodular goiter-2,MNG2,Xp22,
OMIM:301220,"Pigment disorder, reticulate (2)","Pigment disorder, reticulate",PDR,Xp22-p21,
OMIM:300488,"{Menopause, natural, age at, QTL1} (2)","Menopause, natural, age at, QTL 1",MENOQ1,Xp21.3,
OMIM:312612,"?Retinitis pigmentosa, X-linked recessive, 6 (2)","Retinitis pigmentosa-6, X-linked recessive",RP6,Xp21.3-p21.2,
OMIM:300030,"Deafness, X-linked 3 (2)","Deafness, X-linked 3","DFNX3, DFN4",Xp21.2,
OMIM:300858,"Mental retardation, X-linked, syndromic 17 (2)","Mental retardation, X-linked, syndromic 17",MRXS17,Xp21.1-p11.23,
OMIM:300679,Chromosome Xp21 deletion syndrome (4),Chromosome Xp21 deletion syndrome,"DELXp21, CXDELp21",Xp21,
OMIM:300589,"Nystagmus 5, congenital, X-linked (2)","Nystagmus 5, congenital, X-linked",NYS5,Xp11.4,
OMIM:311050,"Optic atrophy 2, X-linked (2)","Optic atrophy, X-linked",OPA2,Xp11.4-p11.21,
OMIM:300551,"Mental retardation, X-linked 78 (2)","Mental retardation, X-linked 78",MRX78,Xp11.4-q21.1,
OMIM:300578,Chromosome Xp11.3 deletion syndrome (4),Chromosome Xp11.3 deletion syndrome (X-linked mental retardation with retinitis pigmentosa),"DELXp11.3, CXDELp11.3",Xp11.3,
OMIM:300848,"Mental retardation, X-linked 89 (2)","Mental retardation, X-linked 89",MRX89,Xp11.3,
OMIM:300851,"Mental retardation, X-linked 92 (2)","Mental retardation, X-linked 92",MRX92,Xp11.3,
OMIM:300115,"Mental retardation, X-linked 50 (2)","Mental retardation, X-linked nonspecific, type 50",MRX50,Xp11.3-p11.21,
OMIM:300652,Angio serpiginosum (2),"Angioma serptiginosum, X-linked",AGSPX,Xp11.3-q12,
OMIM:300062,"Mental retardation, X-linked 14 (2)","Mental retardation, X-linked-14",MRX14,Xp11.3-q13.3,
OMIM:300218,"Mental retardation, X-linked syndromic 7 (2)","Mental retardation, X-linked, syndromic 7",MRXS7,Xp11.3-q22,
OMIM:300505,"Mental retardation, X-linked 84 (2)","Mental retardation, X-linked 84",MRX84,Xp11.3-q22.3,
OMIM:300801,Chromosome Xp11.23-p11.22 duplication syndrome (4),Chromosome Xp11.23-p11.22 duplication syndrome,"DUPXp11.23p11.22, CXDUPp11.23p11.22",Xp11.23-p11.22,
OMIM:300705,Xp11.22 microduplication syndrome (4),Xp11.22 microduplication syndrome,"DUPXp11.22, MRX17, MRX31",Xp11.22,
OMIM:300704,"{Prostate cancer, hereditary, X-linked 2} (2)","Prostate cancer, hereditary, X-linked 2",HPCX2,Xp11.22,
OMIM:300856,"{Hypospadias 4, X-linked, susceptibility to} (2)","Hypospadias 4, X-linked, susceptibility to",HYSP4,Xp11.22,
OMIM:300504,"Mental retardation, X-linked 52 (2)","Mental retardation, X-linked 52",MRX52,Xp11.21-q22.3,
OMIM:300433,"Mental retardation, X-linked 81 (2)","Mental retardation, X-linked 81",MRX81,Xp11.2-q12,
OMIM:300351,"{Graves disease, susceptibility to, X-linked} (2)","Graves disease, susceptibility to, X-linked","GRDX, GD3",Xp11,
OMIM:300136,"{Diabetes mellitus, insulin-dependent, X-linked} (2)","Diabetes mellitus, insulin-dependent, X-linked, susceptibility to",IDDMX,Xp11,
OMIM:308905,"{Leber optic atrophy, susceptibility to} (2)","Leber optic atrophy, susceptibility to",LOAS,Xp11,
OMIM:309545,"?Mental retardation, X-linked, syndromic 12 (2)","Mental retardation, X-linked, syndromic 12",MRXS12,Xp11,
OMIM:300047,"Mental retardation, X-linked 20 (2)","Mental retardation, X-linked-20",MRX20,Xp11-q21,
OMIM:309610,Prieto syndrome (2),"Prieto syndrome (mental retardation, X-linked, syndromic 2, with dysmorphism and cerebral atrophy)","PRS, MRXS2",Xp11-q21,
OMIM:300082,[Social cognition] (2),"Cognitive function-1, social",CGF1,Xq,
OMIM:300125,"{Migraine, familial typical, susceptibility to, 2} (2)","Migraine, familial typical, susceptibility to, 2",MGR2,Xq,
OMIM:300710,"Alopecia, androgenetic, 2 (2)","Alopecia, androgenetic, 2",AGA2,Xq11-q12,
OMIM:300266,"Spastic paraplegia 16, X-linked, complicated (2)","Spastic paraplegia 16, X-linked, complicated",SPG16,Xq11.2,
OMIM:300406,FG syndrome 3 (2),FG syndrome 3,FGS3,Xp22.3,
OMIM:300454,"Mental retardation, X-linked 77 (2)","Mental retardation, X-linked 77",MRX77,Xq12-q21.3,
OMIM:300709,"Mental retardation, X-linked, syndromic 9 (2)","Mental retardation, X-linked, syndromic 9",MRXS9,Xq12-q21.31,
OMIM:309605,Miles-Carpenter syndrome (2),"Miles-Carpenter syndrome (mental retardation, X-linked, syndromic 4, with congenital contractures and low fingertip arches)","MCS, MRXS4",Xq13-q22,
OMIM:300580,"Myopathy, congenital, with fiber-type disproportion, X-linked (2)","Myopathy, congenital, with fiber-type disproportion, X-linked",CFTDX,Xq13.1-q22.1,
OMIM:300262,"Mental retardation, X-linked syndromic, Abidi type (2)",Abidi X-linked mental retardation syndrome,MRXSAB,Xq13.2,
OMIM:303110,"Choroideremia, deafness, and mental retardation (4)",Chromosome Xq21 deletion syndrome,"DELXq21, CXDELq21",Xq21,
OMIM:300557,{Parkinson disease 12} (2),Parkinson disease-12,PARK12,Xq21-q25,
OMIM:300756,{Alzheimer disease 16} (2),Alzheimer disease 16,AD16,Xq21.3,
OMIM:300861,"Mental retardation, X-linked, syndromic, Chudley-Schwartz type, (2)","Mental retardation, X-linked, syndromic, Chudley-Schwartz type",MRXSCS,Xq21.33-q23,
OMIM:301201,"?Amelogenesis imperfecta, type IE, X-linked 2 (2)","Amelogenesis imperfecta, hypomaturation or hypoplastic type, X-linked 2","AI1E2, AIH3",Xq22-q28,
OMIM:300324,"Mental retardation, X-linked 53 (2)","Mental retardation, X-linked-53",MRX53,Xq22.2-q26,
OMIM:300194,"Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (4)","Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (AMME complex)","AMMEC, DELXq22.3, CXDELq22.3",Xq22.3,
OMIM:300581,FG syndrome 5 (2),FG syndrome 5,FGS5,Xq22.3,
OMIM:300711,"Pyloric stenosis, infantile hypertrophic, 4 (2)","Pyloric stenosis, infantile hypertrophic, 4",IHPS4,Xq23,
OMIM:300046,"Mental retardation, X-linked 23 (2)","Mental retardation, X-linked-23",MRX23,Xq23-q24,
OMIM:300464,"{Coronary heart disease, susceptibility to, 3} (2)","Coronary heart disease, susceptibility to, 3",CHDS3,Xq23-q26,
OMIM:300613,Myopia 13 (2),Myopia 13,MYP13,Xq23-q27.2,
OMIM:300852,"Mental retardation, X-linked 88 (2)","Mental retardation, X-linked 88",MRX88,Xq24,
OMIM:300518,"Mental retardation, X-linked 82 (2)","Mental retardation, X-linked 82",MRX82,Xq24-q25,
OMIM:300378,Radial ray deficiency (2),Radial ray deficiency,RRDX,Xq24-q25,
OMIM:300750,"Spastic paraplegia 34, X-linked (2)","Spastic paraplegia 34, X-linked",SPG34,Xq24-q25,
OMIM:300591,{Stature QTL 6} (2),Stature quantitative trait locus 6,STQTL6,Xq24-q25,
OMIM:300700,Albinism-deafness syndrome (2),Albinism-deafness syndrome,"ADFN, ALDS",Xq24-q26,
OMIM:301845,Bazex syndrome (2),Bazex syndrome,BZX,Xq24-q27,
OMIM:300245,"Ptosis, hereditary congenital 2 (2)","Ptosis, hereditary congenital 2","PTOS2, PTOSX",Xq24-q27.1,
OMIM:304730,Dermoids of cornea (2),Corneal dermoids,CND,Xq24-qter,
OMIM:300779,"Corneal dystrophy, endothelial, X-linked (2)","Corneal dystrophy, endothelial, X-linked",XECD,Xq25,
OMIM:300179,"X inactivation, familial skewed, 2 (2)","X inactivation, familial skewed, 2",SXI2,Xq25-q26,
OMIM:313850,Thoracoabdominal syndrome (2),Thoracoabdominal syndrome,"THAS, TAS",Xq25-q26.1,
OMIM:300660,Leukoencephalopathy with metaphyseal chondrodysplasia (2),Leukoencephalopathy with metaphyseal chondrodysplasia,LKMCD,Xq25-q27,
OMIM:300703,"Spinocerebellar ataxia, X-linked 5 (2)","Spinocerebellar ataxia, X-linked 5",SCAX5,Xq25-q27.1,
OMIM:302802,"Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 (2)","Charcot-Marie-Tooth neuropathy, X-linked recessive, 3",CMTX3,Xq26,
OMIM:309555,Gustavson syndrome (2),"Gustavson mental retardation syndrome (with microcephaly, optic atrophy, deafness)",GUST,Xq26,
OMIM:300372,"Mental retardation, X-linked 42 (2)","Mental retardation, X-linked nonspecific, 42",MRX42,Xq26,
OMIM:313350,Split hand/foot malformation 2 (2),"Split hand/foot malformation, type (ectrodactyly) 2","SHFM2, SHFD2",Xq26,
OMIM:300712,?Craniofacioskeletal syndrome (2),Craniofacioskeletal syndrome,CFSS,Xq26-q27,
OMIM:307700,"Hypoparathyroidism, X-linked (2)",Hypoparathyroidism,"HPT, HPTX, HYPX",Xq26-q27,
OMIM:300155,Retinitis pigmentosa 24 (2),Retinitis pigmentosa-24,RP24,Xq26-q27,
OMIM:300076,Wood neuroimmunologic syndrome (2),"Immunoneurologic syndrome X-linked, of Wood, Black, and Norbury",INDX,Xq26-qter,
OMIM:300942,Chromosome Xq26.3 duplication syndrome (4),Chromosome Xq26.3 duplication syndrome,"CXDUPq26.3, DUPXq26.3, XLAG",Xq26.3,
OMIM:300833,46XX sex reversal 3 (4),46XX sex reversal 3,SRXX3,Xq26.3,
OMIM:300536,[Bone mineral density QTL 4] (2),Bone mineral density QTL 4,BMND4,Xq27,
OMIM:300085,"Cone dystrophy, progressive X-linked, 2 (2)","Cone dystrophy-2, X-linked",COD2,Xq27,
OMIM:300228,Testicular germ cell tumor (2),Testicular germ cell tumor 1,TGCT1,Xq27,
OMIM:301590,"?Microphthalmia, syndromic 4 (2)","Microphthalmia, syndromic 4","MCOPS4, ANOP1",Xq27-q28,
OMIM:300147,"{Prostate cancer, hereditary, X-linked 1} (2)","Prostate cancer, hereditary, X-linked 1",HPCX1,Xq27-q28,
OMIM:307150,"Hypertrichosis, congenital generalized (4)","Hypertrichosis, congenital generalized","HTC2, HCG, CGH, CXINSq27.1,",Xq27.1,
OMIM:300388,"Polymicrogyria, bilateral perisylvian (2)","Polymicrogyria, bilateral perisylvian","BPP, PMGX, CBPS",Xq27.2-q28,
OMIM:300509,"{Dyslexia, susceptibility to, 9} (2)","Dyslexia, susceptibility to, 9",DYX9,Xq27.3,
OMIM:300869,Chromosome Xq27.3-q28 duplication syndrome (4),Chromosome Xq27.3-q28 duplication syndrome,"DUPXq27.3q28, CXDUPq27.3q28",Xq27.3-q28,
OMIM:302000,,"Epidermolysis bullosa, macular type",EBM,Xq27.3-qter,
OMIM:300843,Bornholm eye disease (2),Bornholm eye disease,BED,Xq28,
OMIM:300815,Chromosome Xq28 duplication syndrome (4),Chromosome Xq28 duplication syndrome,"DUPXq28, CXq28",Xq28,
OMIM:309200,{?Major affective disorder 2} (2),Major affective disorder 2,"MAFD2, MDX",Xq28,
OMIM:309620,Mental retardation-skeletal dysplasia (2),Mental retardation-skeletal dysplasia,"MRSD, CHRS",Xq28,
OMIM:300261,"Mental retardation syndrome, X-linked, Armfield type (2)",Armfield X-linked mental retardation syndrome,MRXSA,Xq28,
OMIM:300845,Moyamoya disease 4 (4),"Moyamoya disease 4 with short stature, hypergonadotropic hypogonadism and facial dysmorphism","MYMY4, CXDELq38",Xq28,
OMIM:310460,Myopia-1 (2),"Myopia 1, X-linked",MYP1,Xq28,
OMIM:300605,Retinitis pigmentosa 34 (2),Retinitis pigmentosa 34,RP34,Xq28,
OMIM:300809,"{Systemic lupus erthematosus, susceptibility to, 15} (2)","Systemic lupus erythematosus, susceptibility to, 15",SLEB15,Xq28,
OMIM:314300,Goeminne TKCR syndrome (2),"Torticollis, keloids, cryptorchidism and renal dysplasia","TKCR, TKC",Xq28,
OMIM:314900,,Xm,XM,Xq28,
OMIM:300471,Cubitus valgus with mental retardation and unusual facies (2),Cubitus valgus with mental retardation and unusual facies,CVMRF,Chr.X,
OMIM:300719,"Deafness, cataract, retinitis pigmentosa, and sperm abnormalities (2)","Deafness, cataract, retinitis pigmentosa, and sperm abnormalities",DFCTRPS,Chr.X,
OMIM:300331,"Thrombocythemia, X-linked (2)","Thrombocythemia, X-linked",THCYTX,Chr.X,
OMIM:300345,Microphthalmia with coloboma 1 (2),"Microphthalmia, isolated, with coloboma 1",MCOPCB1,Chr.X,
OMIM:300716,"Mental retardation, X-linked 95 (2)","Mental retardation, X-linked 95",MRX95,Chr.X,
OMIM:300612,Brooks-Wisniewski-Brown syndrome (2),Brooks-Wisniewski-Brown syndrome,MRXSBWB,Chr.X,
OMIM:300519,"Mental retardation, X-linked, syndromic, Martin-Probst type (2)","Mental retardation, X-linked, syndromic, Martin-Probst type",MRXSMP,Chr.X,
OMIM:400042,"Spermatogenic failure, Y-linked, 1 (4)",Chromosome Yq11 interstitial deletion syndrome,"DELYq11, CYDELq11, SPGFY1",Yq11,
OMIM:475000,,"Growth control, Y-chromosome influenced","GCY, TSY, STA",Yq12,
OMIM:400043,"Deafness, Y-linked 1 (1)","Deafness, Y-linked 1",DFNY1,Chr.Y,
OMIM:400004,"Retinitis pigmentosa, Y-linked (2)","Retinitis pigmentosa, Y-linked",RPY,Chr.Y,
